<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more) - Middleton, P - 2017 | Cochrane Library</title> <meta content="Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more) - Middleton, P - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005302.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more) - Middleton, P - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005302.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005302.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more)" name="citation_title"/> <meta content="Philippa Middleton" name="citation_author"/> <meta content="Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute" name="citation_author_institution"/> <meta content="philippa.middleton@adelaide.edu.au" name="citation_author_email"/> <meta content="Emily Shepherd" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Vicki Flenady" name="citation_author"/> <meta content="Mater Research Institute ‐ The University of Queensland (MRI‐UQ)" name="citation_author_institution"/> <meta content="Rosemary D McBain" name="citation_author"/> <meta content="The University of Adelaide" name="citation_author_institution"/> <meta content="Caroline A Crowther" name="citation_author"/> <meta content="The University of Auckland" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD005302.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/01/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005302.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005302.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005302.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Fetal Membranes, Premature Rupture; *Term Birth; *Watchful Waiting; Cesarean Section [statistics &amp; numerical data]; Labor, Induced [*methods]; Misoprostol [administration &amp; dosage]; Obstetric Labor Complications; Oxytocics [administration &amp; dosage]; Oxytocin [administration &amp; dosage]; Pregnancy Outcome; Prostaglandins [administration &amp; dosage]; Randomized Controlled Trials as Topic; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005302.pub3&amp;doi=10.1002/14651858.CD005302.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="sogqpCtr";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005302\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005302\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ja","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005302.pub3",title:"Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more)",firstPublishedDate:"Jan 4, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005302.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005302.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005302.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005302.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005302.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005302.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005302.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005302.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005302.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005302.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>21271 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005302.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-sec-0149"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-sec-0084"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-sec-0143"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/appendices#CD005302-sec-0154"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/table_n/CD005302StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/table_n/CD005302StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more) </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#CD005302-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Philippa Middleton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#CD005302-cr-0003">Emily Shepherd</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#CD005302-cr-0004">Vicki Flenady</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#CD005302-cr-0005">Rosemary D McBain</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information#CD005302-cr-0006">Caroline A Crowther</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information/en#CD005302-sec-0164">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 January 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005302.pub3">https://doi.org/10.1002/14651858.CD005302.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005302-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005302-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD005302-abs-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD005302-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005302-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005302-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005302-abs-0001" lang="en"> <section id="CD005302-sec-0001"> <h3 class="title" id="CD005302-sec-0001">Background</h3> <p>Prelabour rupture of membranes (PROM) at term is managed expectantly or by planned early birth. It is not clear if waiting for birth to occur spontaneously is better than intervening, e.g. by inducing labour. </p> </section> <section id="CD005302-sec-0002"> <h3 class="title" id="CD005302-sec-0002">Objectives</h3> <p>The objective of this review is to assess the effects of planned early birth (immediate intervention or intervention within 24 hours) when compared with expectant management (no planned intervention within 24 hours) for women with term PROM on maternal, fetal and neonatal outcomes. </p> </section> <section id="CD005302-sec-0003"> <h3 class="title" id="CD005302-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth's Trials Register (9 September 2016) and reference lists of retrieved studies. </p> </section> <section id="CD005302-sec-0004"> <h3 class="title" id="CD005302-sec-0004">Selection criteria</h3> <p>Randomised or quasi‐randomised controlled trials of planned early birth compared with expectant management (either in hospital or at home) in women with PROM at 37 weeks' gestation or later. </p> </section> <section id="CD005302-sec-0005"> <h3 class="title" id="CD005302-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trials for inclusion, extracted the data, and assessed risk of bias of the included studies. Data were checked for accuracy. </p> </section> <section id="CD005302-sec-0006"> <h3 class="title" id="CD005302-sec-0006">Main results</h3> <p>Twenty‐three trials involving 8615 women and their babies were included in the update of this review. Ten trials assessed intravenous oxytocin; 12 trials assessed prostaglandins (six trials in the form of vaginal prostaglandin E2 and six as oral, sublingual or vaginal misoprostol); and one trial each assessed <i>Caulophyllum</i> and acupuncture. Overall, three trials were judged to be at low risk of bias, while the other 20 were at unclear or high risk of bias. </p> <p>Primary outcomes: women who had planned early birth were at a reduced risk of <b>maternal infectious morbidity (chorioamnionitis and/or endometritis)</b> than women who had expectant management following term prelabour rupture of membranes (average risk ratio (RR) 0.49; 95% confidence interval (CI) 0.33 to 0.72; eight trials, 6864 women; Tau² = 0.19; I² = 72%; <i>low‐quality evidence</i>), and their neonates were less likely to have <b>definite or probable early‐onset neonatal sepsis</b> (RR 0.73; 95% CI 0.58 to 0.92; 16 trials, 7314 infants;<i>low‐quality evidence</i>). No clear differences between the planned early birth and expectant management groups were seen for the risk of <b>caesarean section</b> (average RR 0.84; 95% CI 0.69 to 1.04; 23 trials, 8576 women; Tau² = 0.10; I² = 55%; <i>low‐quality evidence</i>); <b>serious maternal morbidity or mortality</b> (no events; three trials; 425 women; <i>very low‐quality evidence</i>); <b>definite early‐onset neonatal sepsis</b> (RR 0.57; 95% CI 0.24 to 1.33; six trials, 1303 infants; <i>very low‐quality evidence</i>); or <b>perinatal mortality</b> (RR 0.47; 95% CI 0.13 to 1.66; eight trials, 6392 infants; <i>moderate‐quality evidence</i>). </p> <p>Secondary outcomes: women who had a planned early birth were at a reduced risk of chorioamnionitis (average RR 0.55; 95% CI 0.37 to 0.82; eight trials, 6874 women; Tau² = 0.19; I² = 73%), and postpartum septicaemia (RR 0.26; 95% CI 0.07 to 0.96; three trials, 263 women), and their neonates were less likely to receive antibiotics (average RR 0.61; 95% CI 0.44 to 0.84; 10 trials, 6427 infants; Tau² = 0.06; I² = 32%). Women in the planned early birth group were more likely to have their labour induced (average RR 3.41; 95% CI 2.87 to 4.06; 12 trials, 6945 women; Tau² = 0.05; I² = 71%), had a shorter time from rupture of membranes to birth (mean difference (MD) ‐10.10 hours; 95% CI ‐12.15 to ‐8.06; nine trials, 1484 women; Tau² = 5.81; I² = 60%), and their neonates had lower birthweights (MD ‐79.25 g; 95% CI ‐124.96 to ‐33.55; five trials, 1043 infants). Women who had a planned early birth had a shorter length of hospitalisation (MD ‐0.79 days; 95% CI ‐1.20 to ‐0.38; two trials, 748 women; Tau² = 0.05; I² = 59%), and their neonates were less likely to be admitted to the neonatal special or intensive care unit (RR 0.75; 95% CI 0.66 to 0.85; eight trials, 6179 infants), and had a shorter duration of hospital (‐11.00 hours; 95% CI ‐21.96 to ‐0.04; one trial, 182 infants) or special or intensive care unit stay (RR 0.72; 95% CI 0.61 to 0.85; four trials, 5691 infants). Women in the planned early birth group had more positive experiences compared with women in the expectant management group. </p> <p>No clear differences between groups were observed for endometritis; postpartum pyrexia; postpartum antibiotic usage; caesarean for fetal distress; operative vaginal birth; uterine rupture; epidural analgesia; postpartum haemorrhage; adverse effects; cord prolapse; stillbirth; neonatal mortality; pneumonia; Apgar score less than seven at five minutes; use of mechanical ventilation; or abnormality on cerebral ultrasound (no events). </p> <p>None of the trials reported on breastfeeding; postnatal depression; gestational age at birth; meningitis; respiratory distress syndrome; necrotising enterocolitis; neonatal encephalopathy; or disability at childhood follow‐up. </p> <p>In subgroup analyses, there were no clear patterns of differential effects for method of induction, parity, use of maternal antibiotic prophylaxis, or digital vaginal examination. Results of the sensitivity analyses based on trial quality were consistent with those of the main analysis, except for <b>definite or probable early‐onset neonatal sepsis</b> where no clear difference was observed. </p> </section> <section id="CD005302-sec-0007"> <h3 class="title" id="CD005302-sec-0007">Authors' conclusions</h3> <p>There is low quality evidence to suggest that planned early birth (with induction methods such as oxytocin or prostaglandins) reduces the risk of maternal infectious morbidity compared with expectant management for PROM at 37 weeks' gestation or later, without an apparent increased risk of caesarean section. Evidence was mainly downgraded due to the majority of studies contributing data having some serious design limitations, and for most outcomes estimates were imprecise. </p> <p>Although the 23 included trials in this review involved a large number of women and babies, the quality of the trials and evidence was not high overall, and there was limited reporting for a number of important outcomes. Thus further evidence assessing the benefits or harms of planned early birth compared with expectant management, considering maternal, fetal, neonatal and longer‐term childhood outcomes, and the use of health services, would be valuable. Any future trials should be adequately designed and powered to evaluate the effects on short‐ and long‐term outcomes. Standardisation of outcomes and their definitions, including for the assessment of maternal and neonatal infection, would be beneficial. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005302-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005302-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD005302-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD005302-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005302-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005302-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005302-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005302-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005302-abs-0003" lang="en"> <h3>Is it better for a baby to be born immediately or to wait for labour to start spontaneously when waters break at or after 37 weeks? </h3> <p><b>What is the issue?</b> </p> <p>If a pregnant woman's waters break without onset of contractions (prelabour rupture of membranes – PROM) at 37 weeks of pregnancy or more, there are two options: the first is for induction of labour so that the baby is born as soon as possible (planned early birth); or secondly, to wait for labour to start naturally (expectant management). </p> <p><b>Why is this important?</b> </p> <p>In a previous version of this review we found that planned early birth may reduce the risk of maternal infection without increasing the risk of caesarean section, compared with waiting. Fewer infants went to the neonatal intensive care unit with planned early birth, though there were no differences seen in rates of neonatal infection. While there are some benefits of early induction of labour, it is important to have a more complete picture of what happens with planned early birth compared with waiting for labour to start naturally. </p> <p><b>What evidence did we find?</b> </p> <p>This review included data from 23 randomised controlled trials involving 8615 pregnant women at 37 weeks of pregnancy or more. Only three trials were at overall low risk of bias, and the evidence in the review was very low to moderate quality. For planned early birth, 10 trials used intravenous oxytocin for induction of labour, 12 trials used prostaglandins, and one trial each assessed <i>Caulophyllum</i> and acupuncture. </p> <p>The findings showed that planned early birth for PROM at term reduced the risk of infection for pregnant women (including infection of the membranes surrounding the baby and the amniotic fluid (known as chorioamnionitis)) compared with expectant management (eight trials, 6864 women; this was rated <i>low‐quality evidence</i> ), Planned early birth also reduced the risk of definite or possible infections for the babies (16 trials, 7314 babies, <i>low‐quality evidenc</i> e). However, no differences were seen in the rates of caesarean births (23 trials, 8576 women, <i>low‐quality evidence</i> ), serious illness or death for the women (three trials, 425 women, <i>very low‐quality evidence</i> ), definite infection for the babies (six trials, 1303 babies, <i>very low‐quality evidence</i> ), or death for the babies (eight trials, 6392 babies, <i>moderate‐quality evidence</i>). Babies born after planned early birth were less likely to be admitted to the intensive care unit (eight trials, 6179 babies), and both women (two trials, 748 women) and their babies (four trials, 5691 babies) had a shorter stay in hospital after planned early birth. Women had a more positive experience of planned early birth compared with expectant management (two trials, 5134 women). </p> <p><b>What does this mean?</b> </p> <p>Planned early birth (compared with expectant management) after PROM at term may help to reduce infection for women without increasing the need for a caesarean section, and neonatal infection may also be reduced. However, evidence about longer‐term effects on children is needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005302-sec-0149" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005302-sec-0149"></div> <h3 class="title" id="CD005302-sec-0150">Implications for practice</h3> <section id="CD005302-sec-0150"> <p>There is low‐quality evidence to suggest that planned early birth (with induction methods such as oxytocin or prostaglandins) reduces the risk of maternal infectious morbidity (chorioamnionitis and/or endometritis) and definite or probable neonatal sepsis compared with expectant management for prelabour rupture of membranes (PROM) at 37 weeks' gestation or later, without increasing the risk of caesarean birth. Very low‐ to moderate‐quality evidence suggests no clear differences between planned early birth and expectant management for serious maternal morbidity or mortality, perinatal mortality and definite neonatal sepsis. Women should be appropriately counselled in order to make an informed choice between planned early birth and expectant management for PROM at 37 weeks' gestation or later. </p> </section> <h3 class="title" id="CD005302-sec-0151">Implications for research</h3> <section id="CD005302-sec-0151"> <p>Although the 23 included trials in this review involved a large number of women and babies, the quality of the trials and evidence was not high overall, and there was very limited reporting of data for a number of important outcomes. Thus, further evidence assessing the benefits or harms of planned early birth compared with expectant management, considering maternal, fetal, neonatal and longer‐term childhood outcomes, and the use of health services, would be valuable. Any future trials should be adequately designed (including appropriate randomisation processes and blinding of outcome assessment) and powered to evaluate the effects on short‐ and longer‐term outcomes. Standardisation of outcomes and their definitions, including for the assessment of maternal and neonatal infection, would be beneficial. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005302-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005302-sec-0029"></div> <div class="table" id="CD005302-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Planned early birth versus expectant management for prelabour rupture of the membranes at term</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Planned early birth versus expectant management for prelabour rupture of the membranes at term </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with prelabour rupture of membranes at term (37 weeks' gestation or later)<br/> <b>Setting:</b> hospital settings<br/> <b>Intervention:</b> planned early birth<br/> <b>Comparison:</b> expectant management </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with expectant management</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with planned early birth</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Maternal infectious morbidity (chorioamnionitis and/or endometritis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>average RR 0.49<br/> (0.33 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6864<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000<br/> (36 to 79) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>average RR 0.84<br/> (0.69 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8576<br/> (23 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>126 per 1000<br/> (104 to 156) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>425<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>no events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>no events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Definite early‐onset neonatal sepsis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.57<br/> (0.24 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1303<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000<br/> (5 to 29) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Definite or probable early‐onset neonatal sepsis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/> (0.58 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7314<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/> (24 to 38) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth or neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.47<br/> (0.13 to 1.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6392<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (0 to 4) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations (‐1): Most of the studies contributing data had design limitations, dominated by a study with low risk of bias </p> <p><sup>2</sup> Inconsistency (‐1): Substantial heterogeneity </p> <p><sup>3</sup> Imprecision (‐1): Wide 95% CI crossing the line of no effect </p> <p><sup>4</sup> Imprecision (‐2): No events; three trials with relatively small sample sizes </p> <p><sup>5</sup> Study limitations (‐2): Most of the studies contributing data had serious design limitations (‐2) </p> <p><sup>6</sup> Imprecision (‐2): Low event rate and wide 95% CI crossing the line of no effect </p> <p><sup>7</sup> Indirectness (‐1): Substantial variation in outcome measurement and reporting of neonatal sepsis </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005302-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005302-sec-0030"></div> <section id="CD005302-sec-0031"> <h3 class="title" id="CD005302-sec-0031">Description of the condition</h3> <p>Prelabour rupture of membranes (PROM) is defined as rupture of membranes (ROM) prior to the onset of labour (<a href="./references#CD005302-bbs2-0067" title="DuffP . Premature rupture of the membranes in term patients: induction of labor versus expectant management. Clinical Obstetrics and Gynecology1998;41(4):883‐91. ">Duff 1998</a>). PROM most frequently occurs at term (37 weeks or more of gestation) (<a href="./references#CD005302-bbs2-0067" title="DuffP . Premature rupture of the membranes in term patients: induction of labor versus expectant management. Clinical Obstetrics and Gynecology1998;41(4):883‐91. ">Duff 1998</a>), with the overall incidence of PROM at term being approximately 8% (<a href="./references#CD005302-bbs2-0063" title="CammuH , VerlaenenH , DerdeM . Premature rupture of membranes at term in nulliparous women: a hazard?. Obstetrics &amp; Gynecology1990;76:671‐4. ">Cammu 1990</a>). Spontaneous onset of labour after term PROM usually follows within 24 hours (<a href="./references#CD005302-bbs2-0063" title="CammuH , VerlaenenH , DerdeM . Premature rupture of membranes at term in nulliparous women: a hazard?. Obstetrics &amp; Gynecology1990;76:671‐4. ">Cammu 1990</a>), with 79% of women labouring spontaneously within 12 hours, and 95% within 24 hours (<a href="./references#CD005302-bbs2-0064" title="ConwayD , PrendivilleW , MorrisA , SpellerD , StirratG . Management of spontaneous rupture of the membranes in the absence of labor in primigravid women at term. American Journal of Obstetrics and Gynecology1984;150:947‐51. ">Conway 1984</a>; <a href="./references#CD005302-bbs2-0089" title="ZlatnikFJ . Management of premature rupture of membranes at term. Obstetrics and Gynecology Clinics of North America1992;19(2):353‐64. ">Zlatnik 1992</a>). Even when the state of the cervix is unfavourable, the majority of women labour spontaneously within 24 hours (<a href="./references#CD005302-bbs2-0073" title="HannahM , SeawardG . Prelabour rupture of membranes at term: the role of induction of labour. Fetal and Maternal Medicine Review1998;10:61‐8. ">Hannah 1998</a>). However, if the woman does not labour within 24 hours, labour may be delayed up to seven days after membrane rupture (<a href="./references#CD005302-bbs2-0073" title="HannahM , SeawardG . Prelabour rupture of membranes at term: the role of induction of labour. Fetal and Maternal Medicine Review1998;10:61‐8. ">Hannah 1998</a>), with longer latent periods in nulliparous women (<a href="./references#CD005302-bbs2-0089" title="ZlatnikFJ . Management of premature rupture of membranes at term. Obstetrics and Gynecology Clinics of North America1992;19(2):353‐64. ">Zlatnik 1992</a>). </p> <p>PROM at term is known to be associated with overdistension of the uterus due to multiple pregnancy or polyhydramnios (abnormally high levels of amniotic fluid), cigarette smoking, altered mechanical properties of the amniotic membranes, frequent digital examinations, coitus and infection (<a href="./references#CD005302-bbs2-0067" title="DuffP . Premature rupture of the membranes in term patients: induction of labor versus expectant management. Clinical Obstetrics and Gynecology1998;41(4):883‐91. ">Duff 1998</a>; <a href="./references#CD005302-bbs2-0073" title="HannahM , SeawardG . Prelabour rupture of membranes at term: the role of induction of labour. Fetal and Maternal Medicine Review1998;10:61‐8. ">Hannah 1998</a>), although it is not clear if these are causally related to PROM (<a href="./references#CD005302-bbs2-0073" title="HannahM , SeawardG . Prelabour rupture of membranes at term: the role of induction of labour. Fetal and Maternal Medicine Review1998;10:61‐8. ">Hannah 1998</a>). </p> </section> <section id="CD005302-sec-0032"> <h3 class="title" id="CD005302-sec-0032">Description of the intervention</h3> <p>PROM at term may be managed expectantly or by elective birth, usually by induction of labour. Planned elective early birth is usually termed active or planned early birth. Expectant management involves waiting for labour to occur and then making management decisions (such as inducing labour) if labour does not happen spontaneously after a specified period. </p> <p>PROM may result in immediate risks such as cord prolapse, cord compression and placental abruption; and later problems including maternal or neonatal infection, as well as the use of interventions such as caesarean section and instrumental vaginal birth (<a href="./references#CD005302-bbs2-0061" title="AlexanderJ , CoxS . Clinical course of premature rupture of the membranes. Seminars in Perinatology1996;20(5):369‐74. ">Alexander 1996</a>; <a href="./references#CD005302-bbs2-0077" title="KongAS , BatesSJ , RizkB . Rupture of membranes before the onset of spontaneous labour increases the likelihood of instrumental delivery. British Journal of Anaesthesia1992;68:252‐5. ">Kong 1992</a>; <a href="./references#CD005302-bbs2-0079" title="MerensteinG , WeismanL . Premature rupture of the membranes: neonatal consequences. Seminars in Perinatology1996;20(5):375‐80. ">Merenstein 1996</a>). Expectant management of term PROM has been associated with maternal infections including chorioamnionitis (inflammation of the membranes) or endometritis (generally a postpartum infection). These infections may result in neonatal infection and mortality, chronic lung disease and cerebral palsy (<a href="./references#CD005302-bbs2-0063" title="CammuH , VerlaenenH , DerdeM . Premature rupture of membranes at term in nulliparous women: a hazard?. Obstetrics &amp; Gynecology1990;76:671‐4. ">Cammu 1990</a><i>;</i><a href="./references#CD005302-bbs2-0069" title="GonenR , HannahM , MilliganJ . Does prolonged preterm premature rupture of the membranes predispose to abruptio placentae?. Obstetrics &amp; Gynecology1989;74:347‐50. ">Gonen 1989</a><i>;</i><a href="./references#CD005302-bbs2-0079" title="MerensteinG , WeismanL . Premature rupture of the membranes: neonatal consequences. Seminars in Perinatology1996;20(5):375‐80. ">Merenstein 1996</a>; <a href="./references#CD005302-bbs2-0085" title="RobsonMS , TurnerMJ , StrongeJM , O'HerlihyC . Is amniotic fluid quantitation of value in the diagnosis and conservative management of prelabour rupture of membranes at term?. British Journal of Obstetrics and Gynaecology1990;97(4):324‐8. ">Robson 1990</a>; <a href="./references#CD005302-bbs2-0089" title="ZlatnikFJ . Management of premature rupture of membranes at term. Obstetrics and Gynecology Clinics of North America1992;19(2):353‐64. ">Zlatnik 1992</a>), as well as serious morbidity for the mother. Some reports have suggested that the risk of maternal and fetal infection increases proportionally with the time between membrane rupture and birth (<a href="./references#CD005302-bbs2-0068" title="GafniA , GoereeR , MyhrT , HannahM , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. ">Gafni 1997</a>; <a href="./references#CD005302-bbs2-0089" title="ZlatnikFJ . Management of premature rupture of membranes at term. Obstetrics and Gynecology Clinics of North America1992;19(2):353‐64. ">Zlatnik 1992</a>), while others refute this (<a href="./references#CD005302-bbs2-0073" title="HannahM , SeawardG . Prelabour rupture of membranes at term: the role of induction of labour. Fetal and Maternal Medicine Review1998;10:61‐8. ">Hannah 1998</a>; <a href="./references#CD005302-bbs2-0086" title="SeawardP , HannahM , MyhrT , FarineD , OhlssonA , WangE , et al. International Multicentre Term Prelabour Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabour rupture of membranes at term. American Journal of Obstetrics and Gynecology1997;177:1024‐9. ">Seaward 1997</a>). Whether or not to induce labour may depend on the state of the cervix, with an insufficiently ripe cervix resulting in increased length of labour and failed induction requiring caesarean section (<a href="./references#CD005302-bbs2-0063" title="CammuH , VerlaenenH , DerdeM . Premature rupture of membranes at term in nulliparous women: a hazard?. Obstetrics &amp; Gynecology1990;76:671‐4. ">Cammu 1990</a>; <a href="./references#CD005302-bbs2-0066" title="DuffP . Premature rupture of the membranes in term patients. Seminars in Perinatology1996;20(5):401‐8. ">Duff 1996</a>; <a href="./references#CD005302-bbs2-0067" title="DuffP . Premature rupture of the membranes in term patients: induction of labor versus expectant management. Clinical Obstetrics and Gynecology1998;41(4):883‐91. ">Duff 1998</a>; <a href="./references#CD005302-bbs2-0088" title="YawnB , WollanP , McKeonK , FieldC . Temporal changes in rates and reasons for medical induction of term labor, 1980‐1996. American Journal of Obstetrics and Gynecology2001;184:611‐9. ">Yawn 2001</a>)<i>.</i> Uterine rupture has been reported, but only rarely. </p> </section> <section id="CD005302-sec-0033"> <h3 class="title" id="CD005302-sec-0033">How the intervention might work</h3> <p>There are conflicting conclusions from literature reviews assessing PROM at term. <a href="./references#CD005302-bbs2-0072" title="HallakM , BottomsS . Induction of labour in patients with term premature rupture of membranes. Fetal Diagnosis and Therapy1999;14:128‐42. ">Hallak 1999</a> found that with a longer interval from admission to the onset of labour, there is an increased incidence of neonatal intensive care unit admission, caesarean section and more frequent maternal diarrhoea and use of analgesia or anaesthesia. Induction of labour is supported by a retrospective study (<a href="./references#CD005302-bbs2-0076" title="JohnsonJWC , DaikokuNH , NiebylJR , JohnsonTRB , KhouzamiVA , WitterFR . Premature rupture of the membranes and prolonged latency. Journal of the American College of Obstetricians and Gynecologists1981;57(5):547‐56. ">Johnson 1981</a>), which reported increased perinatal mortality and intrapartum fever in women at term when there was delay of more than 72 hours between PROM and birth. Oxytocin infusion was recommended as the gold standard management of PROM at term in a review (<a href="./references#CD005302-bbs2-0065" title="CraneJ , YoungD . Induction of labour with a favourable cervix and/or pre‐labour rupture of membranes. Best Practice &amp; Research. Clinical Obstetrics &amp; Gynaecology2003;17(5):795‐809. ">Crane 2003</a>). These results are in contrast to the findings of <a href="./references#CD005302-bbs2-0070" title="GuiseJ , DuffP , ChristianJ . Management of term patients with premature rupture of membranes and an unfavorable cervix. American Journal of Perinatology1992;9(1):56‐60. ">Guise 1992</a>, who reported that induction of labour results in increased frequency of chorioamnionitis, neonatal sepsis, caesarean section and longer duration of hospitalisation. <a href="./references#CD005302-bbs2-0082" title="MozurkewichE , WolfF . Premature rupture of membranes at term: a meta‐analysis of three management systems. Obstetrics and Gynecology1997;89:1035‐43. ">Mozurkewich 1997</a> highlighted the risks and benefits of induction of labour, with reduced rates of chorioamnionitis, endometritis and neonatal infection, and an increased rate of caesarean section. Induction of labour for women with PROM at term may incur fewer costs than expectant management (<a href="./references#CD005302-bbs2-0068" title="GafniA , GoereeR , MyhrT , HannahM , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. ">Gafni 1997</a>). Women may be more satisfied with care when there is a short time between PROM and birth (<a href="./references#CD005302-bbs2-0074" title="HannahM . Commentary: managing labor: what do women really want?. Birth1999;26(2):97‐8. ">Hannah 1999</a>). </p> </section> <section id="CD005302-sec-0034"> <h3 class="title" id="CD005302-sec-0034">Why it is important to do this review</h3> <p>This review updates a previously published Cochrane review on planned early birth versus expectant management (waiting) for PROM at term (<a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>), which included 12 randomised controlled trials, and found that planned early birth may reduce the risk of maternal infectious morbidity without increasing the risk of caesarean section or operative vaginal birth (<a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>). The review found that fewer infants went to the neonatal intensive care unit with planned early birth, though no clear differences were seen in neonatal infection rates (<a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>). It was concluded that while there may be some benefits of planned early birth, since the differences in outcomes may not be substantial, women need to be able to access the appropriate information to make an informed choice, and further research is required to assess outcomes such as maternal satisfaction, maternal and neonatal infectious morbidity and longer‐term child development/disability (<a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>). </p> <p>Another Cochrane review has evaluated the management of women with preterm PROM between 24 and 37 weeks' gestation and found insufficient evidence to guide clinical practice, with methodological weaknesses in the clinical trials conducted to date (<a href="./references#CD005302-bbs2-0062" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735] ">Buchanan 2010</a>). Our review focuses on women with PROM at term (37 weeks' gestation or later). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005302-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005302-sec-0035"></div> <p>The objective of this review is to assess the effects of planned early birth (immediate intervention or intervention within 24 hours) when compared with expectant management (no planned intervention within 24 hours) for women with term PROM on maternal, fetal and neonatal outcomes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005302-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005302-sec-0036"></div> <section id="CD005302-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005302-sec-0038"> <h4 class="title">Types of studies</h4> <p>All randomised and quasi‐randomised trials that compared planned early birth with expectant management at term. We planned to exclude studies using a cross‐over design, and planned to include cluster‐randomised trials and trials only reported as abstracts. </p> </section> <section id="CD005302-sec-0039"> <h4 class="title">Types of participants</h4> <p>Women with PROM of at least 37 weeks' gestation with no specific maternal or fetal contraindications to expectant management. </p> </section> <section id="CD005302-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Planned early birth was compared with expectant management (either in hospital or at home). </p> <p>For an intervention to be considered 'planned early birth', a decision must have been made to expedite birth after PROM through some form of induction of labour or by caesarean section. The planned intervention must have been implemented (or was intended to be implemented) within 24 hours of randomisation. </p> <p>Conversely, 'expectant management' must have been associated with an intended delay of at least 24 hours. </p> </section> <section id="CD005302-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>We aimed to examine the effect of planned early birth or expectant management on clinically important outcome measures of maternal and infant morbidity and mortality. We also explored health service utilisation. </p> <section id="CD005302-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>Primary outcomes were chosen to be most representative of the clinically important measures of effectiveness and complications. We assessed the primary outcome of maternal infectious morbidity (chorioamnionitis and/or endometritis), and explored its individual components as secondary outcomes. Primary outcomes were as follows. </p> <section id="CD005302-sec-0043"> <h6 class="title">For the mother</h6> <p> <ul id="CD005302-list-0001"> <li> <p>Maternal infectious morbidity (chorioamnionitis and/or endometritis).</p> </li> <li> <p>Caesarean section.</p> </li> <li> <p>Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit). </p> </li> </ul> </p> </section> <section id="CD005302-sec-0044"> <h6 class="title">For the fetus/neonate</h6> <p> <ul id="CD005302-list-0002"> <li> <p>Definite early‐onset neonatal sepsis.</p> </li> <li> <p>Definite or probable early‐onset neonatal sepsis.</p> </li> <li> <p>Perinatal mortality (stillbirth or neonatal mortality).</p> </li> </ul> </p> </section> </section> <section id="CD005302-sec-0045"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes included other measures of morbidity and mortality, effectiveness, complications, and health service utilisation. </p> <section id="CD005302-sec-0046"> <h6 class="title">For the mother</h6> <p> <ul id="CD005302-list-0003"> <li> <p>Chorioamnionitis (either suspected or proven).</p> </li> <li> <p>Endometritis.</p> </li> <li> <p>Postpartum pyrexia.</p> </li> <li> <p>Postpartum septicaemia.</p> </li> <li> <p>Postpartum antibiotic usage.</p> </li> <li> <p>Caesarean section for fetal distress.</p> </li> <li> <p>Induction of labour.</p> </li> <li> <p>Operative vaginal birth.</p> </li> <li> <p>Uterine rupture.</p> </li> <li> <p>Epidural analgesia.</p> </li> <li> <p>Postpartum haemorrhage.</p> </li> <li> <p>Adverse effects.</p> </li> <li> <p>Views of care.</p> </li> <li> <p>Breastfeeding, including initiated in hospital and on discharge from hospital.</p> </li> <li> <p>Postnatal depression.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0047"> <h6 class="title">For the fetus/neonate/child</h6> <p> <ul id="CD005302-list-0004"> <li> <p>Time from rupture of membranes to birth.</p> </li> <li> <p>Gestational age at birth.</p> </li> <li> <p>Birthweight.</p> </li> <li> <p>Cord prolapse.</p> </li> <li> <p>Stillbirth.</p> </li> <li> <p>Neonatal mortality.</p> </li> <li> <p>Meningitis.</p> </li> <li> <p>Pneumonia.</p> </li> <li> <p>Antibiotic usage.</p> </li> <li> <p>Apgar score less than seven at five minutes.</p> </li> <li> <p>Respiratory distress syndrome.</p> </li> <li> <p>Use of mechanical ventilation.</p> </li> <li> <p>Abnormality on cerebral ultrasound (cystic periventricular leukomalacia; intraventricular haemorrhage). </p> </li> <li> <p>Necrotising enterocolitis.</p> </li> <li> <p>Neonatal encephalopathy.</p> </li> <li> <p>Disability at childhood follow‐up.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0048"> <h6 class="title">Health services</h6> <p> <ul id="CD005302-list-0005"> <li> <p>Duration of maternal antenatal or postnatal stay in hospital.</p> </li> <li> <p>Admission to neonatal special or intensive care unit.</p> </li> <li> <p>Duration of neonatal stay in hospital.</p> </li> <li> <p>Duration of neonatal stay in special or intensive care unit.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0049"> <h6 class="title">Outcome definitions</h6> <p>Where possible, we aimed to employ the below definitions; however acknowledging the likelihood of variable reporting by the included trials, we also included definitions as per the trialists themselves (and have reported these in the results). </p> <p> <ul id="CD005302-list-0006"> <li> <p>Suspected or proven chorioamnionitis: uterine infection prior to birth of the baby diagnosed on clinical signs, including pyrexia, with or without a positive culture result or haematological signs of infection. </p> </li> <li> <p>Endometritis: clinical signs of uterine infection following labour and birth.</p> </li> <li> <p>Postpartum pyrexia: maternal temperature of 38°C or higher.</p> </li> <li> <p>Postpartum septicaemia: maternal positive blood culture in the presence of pyrexia following birth. </p> </li> <li> <p>Definite or probable infection within the first seven days of life/early‐onset sepsis.</p> <ul id="CD005302-list-0007"> <li> <p>Definite infection: positive culture from a normally sterile site.</p> </li> <li> <p>Probable infection: clinical signs and blood count suggestive of infection and a possible causative organism identified (i.e. gastric aspirate, urine antigen). </p> </li> </ul> </li> </ul> </p> </section> </section> </section> </section> <section id="CD005302-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD005302-sec-0051"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (9 September 2016). </p> <p>The Register is a database containing over 22,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<i><b>Specialized Register</b> </i> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD005302-list-0008"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<a href="./references#CD005302-bbs1-0001" title="">Included studies</a>; <a href="./references#CD005302-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD005302-bbs1-0003" title="">Ongoing studies</a>). </p> <p>[For details of additional searching carried in out an earlier version of the review (<a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>), see: <a href="./appendices#CD005302-sec-0155">Appendix 1</a>.] </p> </section> <section id="CD005302-sec-0052"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of retrieved articles.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD005302-sec-0053"> <h3 class="title" id="CD005302-sec-0053">Data collection and analysis</h3> <p>For methods used in the previous version of this review, <i>see</i><a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>. </p> <p>For this update, the following methods were used for assessing the 14 new reports (and the nine new included studies) that were identified as a result of the updated search. Where required, information pertaining to the previously included 12 studies was updated according to methods outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0019" target="_blank">Higgins 2011</a>). </p> <section id="CD005302-sec-0054"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted the third review author. </p> </section> <section id="CD005302-sec-0055"> <h4 class="title">Data extraction and management</h4> <p>At least two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author. Data were entered into Review Manager software (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0031" target="_blank">RevMan 2014</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we contacted authors of the original reports to provide further details. </p> </section> <section id="CD005302-sec-0056"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0019" target="_blank">Higgins 2011</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD005302-sec-0057"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD005302-list-0009"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0058"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD005302-list-0010"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0059"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD005302-list-0011"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0060"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD005302-list-0012"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0061"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the study authors, we planned to re‐include missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD005302-list-0013"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0062"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD005302-list-0014"> <li> <p>low risk of bias (where it was clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review were reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes were reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD005302-sec-0063"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (6) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD005302-sec-0064"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD005302-bbs2-0075" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD005302-sec-0083">Sensitivity analysis</a>. </p> </section> <section id="CD005302-sec-0065"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update, we evaluated the quality of the evidence using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a>. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for specific outcomes. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, inconsistency, imprecision of effect estimates or publication bias. In this review we used the GRADE approach to assess the primary outcomes, as follows. </p> <section id="CD005302-sec-0066"> <h6 class="title">For the mother</h6> <p> <ul id="CD005302-list-0015"> <li> <p>Maternal infectious morbidity (chorioamnionitis and/or endometritis).</p> </li> <li> <p>Caesarean section.</p> </li> <li> <p>Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit). </p> </li> </ul> </p> </section> <section id="CD005302-sec-0067"> <h6 class="title">For the fetus/neonate</h6> <p> <ul id="CD005302-list-0016"> <li> <p>Definite early‐onset neonatal sepsis.</p> </li> <li> <p>Definite or probable early‐onset neonatal sepsis.</p> </li> <li> <p>Perinatal mortality (stillbirth or neonatal mortality).</p> </li> </ul> </p> </section> </section> <section id="CD005302-sec-0068"> <h5 class="title">'Summary of findings' table</h5> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0031" target="_blank">RevMan 2014</a>) in order to create a 'Summary of findings’ table. A summary of the intervention effect and a measure of quality according to the GRADE approach is presented in the 'Summary of findings' table for the primary outcomes. </p> </section> </section> <section id="CD005302-sec-0069"> <h4 class="title">Measures of treatment effect</h4> <section id="CD005302-sec-0070"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD005302-sec-0071"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference. We planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD005302-sec-0072"> <h4 class="title">Unit of analysis issues</h4> <section id="CD005302-sec-0073"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials for inclusion in this review.</p> <p>If cluster‐randomised trials are included in future updates of this review, we plan to include these trials in the analyses along with individually‐randomised trials. Their sample sizes will be adjusted using the methods described in the <i>Handbook</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0019" target="_blank">Higgins 2011</a>) using an estimate of the intra‐cluster correlation co‐efficient (ICC) derived from the trial (if possible), or from another source. If ICCs from other sources are used, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. We plan to also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation units. </p> </section> <section id="CD005302-sec-0074"> <h5 class="title">Other unit of analysis issues</h5> </section> <section id="CD005302-sec-0075"> <h5 class="title">Cross‐over trials</h5> <p>Trials with cross‐over designs were not eligible for inclusion.</p> </section> <section id="CD005302-sec-0076"> <h5 class="title">Multiple pregnancies</h5> <p>We did not identify any eligible studies that included multiple pregnancies. If multiple pregnancies are included in trials included in future updates of this review, we will adjust for clustering in the analyses wherever possible, and use the inverse variance method for adjusted analyses, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0019" target="_blank">Higgins 2011</a>) and in <a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0036" target="_blank">Yelland 2011</a>. </p> </section> <section id="CD005302-sec-0077"> <h5 class="title">Multi‐armed trials</h5> <p>We included trials with more than one treatment groups (e.g. multi‐arm studies). Where appropriate, we created a single pair‐wise comparison. We used methods described in the <i>Handbook</i> (<a href="./references#CD005302-bbs2-0075" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) to ensure that we did not double count participants. </p> </section> </section> <section id="CD005302-sec-0078"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, levels of attrition were noted. In future updates, if more eligible studies are included, the impact of including studies with high levels of missing data in the overall assessment of treatment effect will be explored by using sensitivity analyses. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD005302-sec-0079"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. Where we identified substantial heterogeneity (above 30%), we explored it using pre‐specified subgroup analyses. </p> </section> <section id="CD005302-sec-0080"> <h4 class="title">Assessment of reporting biases</h4> <p>Where there were 10 or more studies in a meta‐analysis we investigated reporting biases (such as publication bias) using funnel plots. We assessed funnel plot asymmetry visually. If asymmetry was suggested by a visual assessment, we planned to perform exploratory analyses to investigate it. </p> </section> <section id="CD005302-sec-0081"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001807.pub2/full#CD001807-bbs2-0031" target="_blank">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where studies were examining the same intervention, and the studies' populations and methods were judged sufficiently similar. </p> <p>Where there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or where substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary has been treated as the average range of possible treatment effects and we have discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we planned to not combine trials. Where we used random‐effects analyses, the results have been presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD005302-sec-0082"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where we identified substantial heterogeneity, we investigated it using subgroup and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis to produce it. </p> <p>We carried out the following subgroup analyses.</p> <p> <ul id="CD005302-list-0017"> <li> <p>Method of induction of labour (e.g. intravenous oxytocin versus vaginal prostaglandin).</p> </li> <li> <p>Parity (e.g. multiparous women versus nulliparous women).</p> </li> <li> <p>Cervical status at baseline (e.g. women with an unfavourable cervix versus women with a favourable cervix). </p> </li> <li> <p>Maternal antibiotic prophylaxis for PROM (e.g. antibiotic prophylaxis versus no antibiotic prophylaxis). </p> </li> <li> <p>Digital vaginal examination at baseline (e.g. women who had digital vaginal examination versus women who did not have vaginal examination). </p> </li> </ul> </p> <p>The rationale for these subgroup analyses was as follows.</p> <p> <ul id="CD005302-list-0018"> <li> <p>(1) Method of induction of labour ‐ some studies have found differences between various methods (such as oxytocin and prostaglandin) and any such differences would be expected to be operating in women with PROM at term. </p> </li> <li> <p>(2) and (3) Differences in outcomes according to parity and state of cervix would be expected ‐ for example, nulliparous women and those with an unfavourable cervix are likely to have longer labours and this in turn may increase the risk of infection of infection and other adverse outcomes. </p> </li> <li> <p>(4) Maternal antibiotic prophylaxis for PROM may be more likely to reduce maternal and neonatal infection than no maternal antibiotic prophylaxis. </p> </li> <li> <p>(5) Women who have digital examination at baseline may be prone to more infections than those who did not have digital vaginal examination. </p> </li> </ul> </p> <p>Primary outcomes were used in subgroup analyses.</p> <p>We assessed subgroup differences by interaction tests available within RevMan (<a href="./references#CD005302-bbs2-0084" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> <section id="CD005302-sec-0083"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out sensitivity analyses to explore the effect of trial quality assessed by adequate sequence generation and concealment of allocation, and blinding of outcome assessment. We excluded studies with 'unclear' or 'high' risk of bias ratings for sequence generation and detection bias from the analyses for primary outcomes. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005302-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005302-sec-0084"></div> <section id="CD005302-sec-0085"> <h3 class="title">Description of studies</h3> <section id="CD005302-sec-0086"> <h4 class="title">Results of the search</h4> <p>The updated search of the Cochrane Pregnancy and Childbirth Group’s Trials Register identified 17 new records, relating to 15 studies. Of these 15 studies, we included eight trials (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>), excluded six studies (<a href="./references#CD005302-bbs2-0026" title="CararachV , SentisJ , BotetF , ForadadaC , ManauD , FiguerasF , et al. Cervical prostaglandin E1 compared with expectant management and with systematic induction in PROM near term, with bad cervical conditions. I‐maternal results. 3rd World Congress of Perinatal Medicine; 1996 Oct 20‐24; San Francisco, USA. 1996:44. ForadadaC , CararachV , SentisJ , BotetF , ManauD , FiguerasF , et al. Cervical prostaglandin E1 compared with expectant management and with systematic induction in PROM near term, with bad cervical conditions. II‐fetal and neonatal results [abstract]. 3rd World Congress of Perinatal Medicine; 1996 Oct 20‐24; San Francisco, USA. 1996:51‐52. ">Cararach 1996</a>; <a href="./references#CD005302-bbs2-0028" title="ChaudhuriS , MitraSN , BiswasPK , BhattacharyyaS . Premature rupture of membranes at term: immediate induction with PGE2 gel compared with delayed induction with oxytocin. Journal of Obstetrics and Gynaecology of India2006;56(3):224‐9. ">Chaudhuri 2006</a>; <a href="./references#CD005302-bbs2-0031" title="DoungtoneN , TanaputY . Management of premature rupture of membranes with unfavorable cervix in term pregnancy. Journal of Obstetrics and Gynaecology1999;11(4):253. ">Doungtone 1999</a>; <a href="./references#CD005302-bbs2-0041" title="LevyR , VaisbuchE , FurmanB , DoitchH , OronS , HagayZ . Prospective randomized clinical trial of immediate induction of labor with oral misoprostol for prelabor rupture of the membranes in women with unfavorable cervix at term [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S44. ">Levy 2005</a>; <a href="./references#CD005302-bbs2-0042" title="LevyR , VaisbuchE , FurmanB , BrownD , VolachV , HagayZJ . Induction of labor with oral misoprostol for premature rupture of membranes at term in women with unfavorable cervix: a randomized, double‐blind, placebo‐controlled trial. Journal of Perinatal Medicine2007;35(2):126‐9. ">Levy 2007</a>; <a href="./references#CD005302-bbs2-0051" title="PoornimaB , DharmaDB . Premature rupture of membranes at term: Immediate induction with PGE 2 gel compared with delayed induction with oxytocin. Journal of Obstetrics and Gynecology of India2011;61(5):516‐8. ">Poornima 2011</a>), and one study is ongoing (<a href="./references#CD005302-bbs2-0060" title="WalfischA . Management of labor in patients with previous cesarian section and premature rupture of membranes who desire TOLAC: comparison between the use of standard expectant management and the double‐balloon catheter device. a prospective randomized study. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 18 August 2015]2014. ">Walfisch 2014</a>); the final report related to a trial already included (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>). We have also included three additional trials in this update ‐ two that were excluded in the previous version of this review (<a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>), and one that was awaiting classification in the previous version of this review (<a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>). See <a href="#CD005302-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD005302-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD005302-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>The one ongoing trial, <a href="./references#CD005302-bbs2-0060" title="WalfischA . Management of labor in patients with previous cesarian section and premature rupture of membranes who desire TOLAC: comparison between the use of standard expectant management and the double‐balloon catheter device. a prospective randomized study. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 18 August 2015]2014. ">Walfisch 2014</a>, plans to assess the management of PROM at 34 weeks' gestation or later for women with previous caesarean sections, comparing standard expectant management with the double‐balloon catheter device. </p> </section> <section id="CD005302-sec-0087"> <h4 class="title">Included studies</h4> <p>This review now has a total of 23 included trials (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>) involving 8615 women and their babies (including the large <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> trial of 5042 women). For further details see <a href="./references#CD005302-sec-0170" title="">Characteristics of included studies</a>. </p> <p>All of the trials included women with singleton pregnancies with PROM at 37 weeks' gestation or later (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>). </p> <p>Five trials were conducted in Pakistan (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>), two were conducted in China (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>), and two in Scotand (<a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>); one trial was conducted across multiple countries (Canada, the UK, Australia, Israel, Sweden and Denmark) (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>); the remaining trials were conducted in Brazil (<a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>), Canada (<a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>), Denmark (<a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>), Germany (<a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>), India (<a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>), Norway (<a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>), Serbia (<a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>), Sweden (<a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>), the Netherlands (<a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>), Turkey (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>), USA (<a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>), and Zimbabwe (<a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>). </p> <p><b>Induction of labour methods</b> </p> <p>Ten trials assessed intravenous oxytocin; 12 assessed prostaglandins (six in the form of vaginal prostaglandin E2 and six as oral, sublingual or vaginal misoprostol); and one trial each assessed <i>Caulophyllum</i> and acupuncture. One trial, <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>, assessed both intravenous oxytocin and vaginal prostaglandin E2. </p> <p><b>Oxytocin</b> </p> <p> <ul id="CD005302-list-0019"> <li> <p><a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>: planned early birth group: immediate induction with intravenous oxytocin (<i>"the infusion rate titrated to contractions, according to local hospital practice"</i>); expectant management group: induction with oxytocin if spontaneous labour had not occurred within 24 hours. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>: planned early birth group: labour immediately induced with intravenous oxytocin, <i>"titrated to contractions, according to local hospital practice"</i> expectant management group: observed for up to four days, then induced with intravenous oxytocin if spontaneous labour had not occurred, or complications occurred. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>: planned early birth group: oxytocin infusion (no further details provided); expectant management group: observation until birth (unless sepsis was suspected, in which case induction with oxytocin). </p> </li> <li> <p><a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>: planned early birth group: induction eight hours after PROM with intravenous oxytocin (<i>"standard induction protocol for our hospital"</i>); expectant management group: observation for 48 hours; induction if group B ß‐haemolytic streptococci detected on screen or culture; if a clinical diagnosis of chorioamnionitis made; or if 48 hours from PROM elapsed and spontaneous labour had not commenced. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>: planned early birth group: induction with intravenous oxytocin, starting at a dose of 2.5 mU/minute, augmented every 20 minutes until adequate contractility achieved; expectant management group: admission to hospital for 48 hours; if labour did not commence within 48 hours, induction with intravenous oxytocin offered. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>: planned early birth group: 12 hours of expectant management followed by oxytocin infusion (starting at 1 mU/minute and increasing as necessary by 1 mU/minute every 20 minutes); expectant management group: 72 hours of expectant management followed by oxytocin infusion. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>: planned early birth group: induction with oxytocin infusion six hours after ROM; expectant management group: induction with oxytocin 24 hours after ROM (initial dose of 4 mU/minutes, increased after 40 minutes by 4 mU every 20 minutes (maximum 32 mU/minute)). </p> </li> <li> <p><a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>: planned early birth group: induction with intravenous oxytocin, starting at a dose of 1 mU to 3 mU/minute, increased by 2 mU to 3 mU/minute every 30 minutes as required; expectant management group: admission to antenatal unit, until contractions started. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>: planned early birth group: induction with oxytocin infusion following randomisation; expectant management group: monitored for signs and symptoms of chorioamnionitis; if labour had not established 24 hours after PROM, oxytocin was commenced. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: planned early birth group: immediate induction with intravenous oxytocin (commenced at 3 mU/minute and increased by 3 mU/minute every 20 minutes as required); expectant management group: transferred to the antepartum ward, and returned to the labour and delivery suite: if signs of infection or fetal distress occurred; when spontaneous labour occurred; 24 hours after ROM for oxytocin if spontaneous labour did not occur. </p> </li> </ul> </p> <p><b>Oral misoprostol</b> </p> <p> <ul id="CD005302-list-0020"> <li> <p><a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>: planned early birth group: induction with oral misoprostol 50 µg every four hours for a maximum of four doses; expectant management group: observation for 24 hours; if vaginal birth was not achieved, labour induced with <i>"oxytocin or prostaglandins".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>: planned early birth group 1: induction with oral misoprostol 50 µg every four hours until active labour was established or to a maximum of six doses; planned early birth group 2: induction with oral misoprostol 100 µg every four hours until active labour was established or to a maximum of six doses; expectant management group: oral placebo (vitamin B6 50 mg); for both groups, if there was no response (i.e. no signs of any abdominal pain) after 24 hours, oxytocin was started according to the hospital protocol. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>: planned early birth group: immediate induction with oral misoprostol (no further details); expectant management: observation for 24 hours; management as per departmental protocol if not in labour after 24 hours. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>: planned early birth group: induction with oral misoprostol (no further details given); expectant management group: left for 24 hours, unless otherwise indicated. </p> </li> </ul> </p> <p><b>Sublingual misoprostol</b> </p> <p> <ul id="CD005302-list-0021"> <li> <p><a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>: planned early birth group: induction with misoprostol 100 µg sublingually, up to five doses, four hours apart (as required); expectant management group: observation for uterine contractions for 24 hours. </p> </li> </ul> </p> <p><b>Vaginal misoprostol</b> </p> <p> <ul id="CD005302-list-0022"> <li> <p><a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>: planned early birth group: induction immediately with vaginal misoprostol (tablet containing 25 µg Prostokos digitally inserted into the posterior fornix) at six hourly intervals, up to a maximum of four doses (a total of 100 µg); if no response after 24 hours, oxytocin was given; expectant management group: monitored on ward for up to 24 hours; oxytocin was commenced after 24 hours if labour had not commenced. </p> </li> </ul> </p> <p><b>Vaginal prostaglandin E2</b> </p> <p> <ul id="CD005302-list-0023"> <li> <p><a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: planned early birth group: induction with prostaglandin E2 gel (3 mg) instilled into the posterior fornix of the vagina; expectant management group: sterile K‐Y jelly (placebo); for both groups, conservative management followed for 24 hours unless intervention was required; an oxytocin infusion for induction or augmentation <i>"was as indicated by Departmental protocol".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>: planned early birth group: immediate induction with vaginal prostaglandin E2 gel (1 mg or 2 mg) inserted into the posterior vaginal fornix; repeated six hours later if labour had not started, followed oxytocin if labour had not started four or more hours later; expectant management group: observation for up to four days, then induction with vaginal prostaglandin E2 gel if spontaneous labour had not occurred, or if complications developed. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>: planned early birth group: induction with prostaglandin E2 gel (2 mg) in the posterior fornix; if uterine activity did not commence, repeat treatment pf PGE2 gel (1 mg) given six hours later; expectant management group: observed for up to 24 hours; both groups received oxytocin if labour did not commence within 24 hours. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>: planned early birth group: induction with prostaglandin E2 gel (1 mg) at admission, administered into the posterior fornix, repeated six hours later if labour was not established; expectant management group: observation for up to 24 hours; both groups received oxytocin if labour did not commence within 24 hours. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: planned early birth group: induction six hours following ROM with prostaglandin E2 gel (Predipil) intracervically, followed by oxytocin three to four hours later; expectant management group: antibiotics, and monitoring every six hours. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>: planned early birth: induction within six hours with intracervical prostaglandin E2 gel; women for whom spontaneous labour had not commenced after 10 hours were 're‐induced' with prostaglandin or oxytocin; expectant management group: expectant management for 24 hours; those who were not in labour after 24 hours were induced (with intracervical prostaglandin E2 gel or oxytocin, depending on cervical ripening). </p> </li> </ul> </p> <p><b>Oral <i>Caulophyllum</i> </b> </p> <p> <ul id="CD005302-list-0024"> <li> <p>Beer 1999: planned early birth group: induction with <i>Caulophyllum</i> (one tablet per hour containing 250 mg <i>Caulophyllum</i> D4, for seven hours or until labour established); expectant management group: placebo (containing only magnesium stearate and wheat‐starch mixture). </p> </li> </ul> </p> <p><b>Acupuncture</b> </p> <p> <ul id="CD005302-list-0025"> <li> <p><a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>: acupuncture group (planned early birth group): women were needled at the point CV4/Ren 4 (Guanyuan) on the "conception vessel" (midline of lower abdomen), with other points needled according to one of three main Traditional Chinese Medicine diagnostic categories; needles remained in place for 30 minutes and additional acupuncture treatment was offered the next day if labour had not commenced; expectant management group: waiting at home for 48 hours if cardiotocogram, temperature and amniotic fluid were normal; for both groups, if labour had not commenced after two days, vaginal misoprostol was administered into the posterior fornix (starting with 50 µg, and then 25 µg every six hours until contractions) (up to eight times). </p> </li> </ul> </p> <p><b>Parity</b> </p> <p>The majority of the trials included both nulliparous and multiparous women (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>); though four of the trials provided data for some outcomes based on parity subgroups (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>). </p> <p>Two trials included only nulliparous women (<a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>), and two trials included only multiparous women (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>). </p> <p><b>Favourable/unfavourable cervix</b> </p> <p>Nine trials included women with both favourable and unfavourable cervices: (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a> reported on baseline 'cervix unripe' (dilated &lt; 3 cm and &lt; 80% effaced) and 'cervix ripe' (dilated ≥ 3cm and ≥ 80% effaced); <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a> reported on baseline modified Bishop score; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>: mean (standard deviation) Bishop scores were 3.5 (4.9) and 3 (5.4) in the planned early birth and expectant management groups, respectively; (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> reported that some women had a vaginal examination with a speculum at baseline, and others a digital vaginal examination at baseline and 'cervix unripe' (dilated &lt; 3 cm and &lt; 80% effaced) or 'cervix ripe' (dilated ≥ 3 cm and ≥ 80% effaced) was determined; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a> and <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>: reported that <i>"All women in both groups had a cervical dilation &lt;3 cm at entry to the trial"</i>; though in <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a><i>"cervical score"</i> at baseline was presented in Figure 1, and ranged from 1 to 8 (with favourable score defined as ≥ 6); and in <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a> cervical score was presented in Table 1 and ranged from 2 to 9; in <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a> Bishop scores were &lt; 5 and &gt; 5 at randomisation; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a> presented cervical score at baseline in Table 1 which ranged from 1 to 10; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a> reported that women were included <i>"regardless of cervical effacement"</i>). </p> <p>Five trials included only women with unfavourable cervices at baseline (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>: no definition provided; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: Bishop score of 4 or less; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: Bishop score less than 6; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>: Bishop score ranged from 1 to 6; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: <i>"unfavorable cervix"</i> (&lt; 2 cm dilated and &lt; 80% effaced) approximated by visual inspection). </p> <p>In nine trials, cervical status at baseline was not reported (<a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a> and <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a> (only reported on cervical dilation of ≤ 3 cm); <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>). </p> <p><b>Antibiotic prophylaxis</b> </p> <p>In five trials, all women received prophylactic antibiotics.</p> <p> <ul id="CD005302-list-0026"> <li> <p><a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>: <i>"In both groups, prophylactic antibiotics were given".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>: <i>"Antibiotics were prophylactically started in both groups".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>: <i>"antibiotic cover... was done in both groups".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>: <i>"All the patients irrespective of duration of PROM were given injectable Ampicillin 500 mg 6 hourly and injectable Gentamycin 80 mg 12 hourly by parenteral route till delivery."</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>: <i>"Ampicillin is routinely given to all our patients with PROM, irrespective of duration of gestation".</i> </p> </li> </ul> </p> <p>In five trials, some women received antibiotics prophylaxis.</p> <p> <ul id="CD005302-list-0027"> <li> <p><a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>: <i>"intravenous ampicillin 1 g every 6 h was started when 24 h of PROM was reached".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>: 16/220 women (eight in each group) were given prophylactic antibiotics because of a positive ß‐haemolytic streptococci test; and a further 9/220 (four in the planned early birth group and five in the expectant management group) received prophylactic antibiotics for intrapartum pyrexia. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>: 9/100 women (four in the planned early birth group and five in the expectant management group) were given prophylactic antibiotics because of a positive ß‐haemolytic streptococci test. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>: women received antibiotics if duration of ROM reached 12 hours. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: women in the expectant management group received antibiotics (ampicillin). </p> </li> </ul> </p> <p>In two trials, prophylactic antibiotics for PROM did not appear to be routinely administered (<a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a> (except in association with caesarean section); <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>: <i>"Prophylactic antibiotic treatment in connection with caesarean section was only given when there were clinical signs of infection"</i>). </p> <p>In 11 trials, the use of antibiotic prophylaxis for PROM was not clear.</p> <p> <ul id="CD005302-list-0028"> <li> <p><a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a> did not report on clearly on prophylactic antibiotic administration; the outcome <i>"Antibiotics before or during labour"</i> was presented in the <i>"Maternal Outcomes"</i> table. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>: <i>"Decisions about other aspects of... maternal care, including the use and timing of antibiotics... were made by the nurse, midwife, or attending physician".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: not reported. </p> </li> </ul> </p> <p><b>Digital vaginal examination</b> </p> <p>In 12 trials, it is was stated (or assumed based on descriptions provided) that all women received digital vaginal examination at baseline (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>: baseline characteristics included 'cervix unripe' or 'cervix ripe' based on 'Digital vaginal examination'; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: investigations included calculation of <i>"baseline Bishop score"</i>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>: <i>"Bishop score was assessed once with sterile gloves, at the time of admission and was restricted until the establishment of active labour";</i><a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a> and <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>: at baseline women received <i>"a sterile digital examination to exclude occult cord prolapse and to assess cervical score"</i>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>: a single sterile vaginal examination to assess state of the cervix and obtain Bishop scores was conducted; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: to determine baseline Bishop scores; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>: <i>"A single sterile digital examination was performed at randomization to assess cervical dilation and effacement and other parameters of the Bishop score"</i>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>: <i>"To note the dilatation and effacement and to confirm the presence of membrane, vaginal examination was done"</i>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>: to determine baseline cervical score (though it was also stated that <i>"Vaginal examinations were minimized until the active phase of labor"</i>); <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>: <i>"Digital vaginal examination was done for assessment of bishop score"</i>). </p> <p>In three trials, some women received digital vaginal examination at baseline. Though <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> reported that <i>"Digital vaginal examinations were avoided,"</i> regarding baseline characteristics, cervical status was reported based on digital vaginal examination for approximately 35% of women; in <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>, though it was reported that "<i>To minimize the risk of iatrogenic amnionitis, no vaginal palpation was performed at time for admission..."</i> it was also reported that <i>"If the woman was assigned to the intervention group, a vaginal palpation was performed"</i>; in <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>, some women were digitally examined <i>"Our general protocol called for no digital examinations until the patients began labor or induction. However, we included those women who otherwise qualified for the study and who had received a single sterile digital examination at admission".</i> </p> <p>In three trials, it was stated (or assumed based on descriptions provided) that women did not routinely receive digital vaginal examination at baseline (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>: <i>"Digital vaginal examination was avoided"</i>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>: <i>"To avoid infection, no digital examination is performed before onset of labour or induction"</i>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>: <i>"Women who were examined digitally were excluded from further study"</i>). </p> <p>In four trials, it was not stated whether women received digital vaginal examination at baseline (<a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>). </p> </section> <section id="CD005302-sec-0088"> <h4 class="title">Excluded studies</h4> <p>We excluded a total of 36 studies from this review, mostly because gestation was only reported as being at term or because some women in the trial may have not reached 37 completed weeks of gestation when their membranes ruptured (<a href="./references#CD005302-bbs2-0024" title="AlcalayM , HourvitzA , ReichmanB , LuskiA , QuintJ , BarkaiG , et al. Prelabour rupture of membranes at term: early induction of labour versus expectant management. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1996;70:129‐33. AlcalayM , ReichmanB , LipitzS , HourvitzA , ChayenB , MashiachS , et al. A prospective randomized study of premature rupture of membranes at term: early induction of labor vs expectant management. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):433. ">Alcalay 1996</a>; <a href="./references#CD005302-bbs2-0025" title="BrosnanC . Trial of active vs conservative approach to induction of labour in patients with prelabour rupture of the membranes at term on serious fetal/neonatal infection. Personal communication1996. ">Brosnan 1996</a>; <a href="./references#CD005302-bbs2-0026" title="CararachV , SentisJ , BotetF , ForadadaC , ManauD , FiguerasF , et al. Cervical prostaglandin E1 compared with expectant management and with systematic induction in PROM near term, with bad cervical conditions. I‐maternal results. 3rd World Congress of Perinatal Medicine; 1996 Oct 20‐24; San Francisco, USA. 1996:44. ForadadaC , CararachV , SentisJ , BotetF , ManauD , FiguerasF , et al. Cervical prostaglandin E1 compared with expectant management and with systematic induction in PROM near term, with bad cervical conditions. II‐fetal and neonatal results [abstract]. 3rd World Congress of Perinatal Medicine; 1996 Oct 20‐24; San Francisco, USA. 1996:51‐52. ">Cararach 1996</a>; <a href="./references#CD005302-bbs2-0027" title="ChangP , LangerO . Premature rupture of membranes at term; a randomized controlled trial. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S148. ">Chang 1997</a>; <a href="./references#CD005302-bbs2-0028" title="ChaudhuriS , MitraSN , BiswasPK , BhattacharyyaS . Premature rupture of membranes at term: immediate induction with PGE2 gel compared with delayed induction with oxytocin. Journal of Obstetrics and Gynaecology of India2006;56(3):224‐9. ">Chaudhuri 2006</a>; <a href="./references#CD005302-bbs2-0029" title="ChuaS , ArulkumaranS , YapC , SelamatN , RatnamSS . Premature rupture of membranes in nulliparas at term with unfavorable cervices: a double‐blind randomized trial of prostaglandin and placebo. Obstetrics &amp; Gynecology1995;86:550‐4. ">Chua 1995</a>; <a href="./references#CD005302-bbs2-0030" title="DaviesNJ , MartindaleE , HaddadNG . Cervical ripening with oral PGE2 tablets and the effect of the latent period in patients with premature rupture of the membranes at term. Proceedings of 2nd European Congress on Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:156. DaviesNJ , MartindaleE , HaddadNG . Cervical ripening with oral prostaglandin E2 tablets and the effect of the latent period in patients with premature rupture of the membranes at term. Journal of Obstetrics and Gynaecology1991;11:405‐8. ">Davies 1991</a>; <a href="./references#CD005302-bbs2-0031" title="DoungtoneN , TanaputY . Management of premature rupture of membranes with unfavorable cervix in term pregnancy. Journal of Obstetrics and Gynaecology1999;11(4):253. ">Doungtone 1999</a>; <a href="./references#CD005302-bbs2-0032" title="DuffP , HuffRW , GibbsRS . Management of premature rupture of membranes and unfavorable cervix in term pregnancy. Obstetrics &amp; Gynecology1984;63(5):697‐702. ">Duff 1984</a>; <a href="./references#CD005302-bbs2-0033" title="FreemanRK , MishellDR . Induction of labor with sparteine sulfate for premature rupture of the fetal membranes near term. Pacific Medicine and Surgery1968;76:43‐7. ">Freeman 1968</a>; <a href="./references#CD005302-bbs2-0034" title="GloebDJ , O'SullivanMJ , BeydounSN . Relationship of the interval between spontaneous premature rupture of the membranes and inducibility of labor. Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 February 1‐4; New Orleans, Louisiana, USA. 1989:493. ">Gloeb 1989</a>; <a href="./references#CD005302-bbs2-0035" title="GonenR , SambergI , DeganiS . Intracervical prostaglandin E2 for induction of labour in patients with premature rupture of membranes and an unripe cervix. American Journal of Perinatology1994;11(6):436‐8. GonenR , SambergI , DeganiS , SharfM . Intracervical prostaglandin E2 for induction of labor in patients with premature rupture of membranes and an unfavourable cervix. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):362. ">Gonen 1994</a>; <a href="./references#CD005302-bbs2-0036" title="GrantJM , SerleE , MahmoodT , SarmandalP , ConwayD . Management of prelabour rupture of the membranes in term primigravidae: report of a randomized prospective trial. British Journal of Obstetrics and Gynaecology1992;99:557‐62. ">Grant 1992</a>; <a href="./references#CD005302-bbs2-0037" title="HidarS , BibiM , JerbiM , BouguizeneS , NouiraM , MellouliR , et al. Contribution of intracervical PGE2 administration in premature rupture of the membranes at term. Prospective randomised clinical trial [Apport de l'administration intracervicale de PGE2 dans les ruptures prematurees des membranes a terme]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2000;29(6):607‐13. ">Hidar 2000</a>; <a href="./references#CD005302-bbs2-0038" title="GranstromL , HammarstromM , HjertbergR , MobergerB , BergA , NorlanderE . Expectant management in nulliparous term pregnant women with premature rupture of membranes and an unripe cervix. Journal of Obstetrics and Gynaecology1995;15:366‐72. HjertbergR , BergA , EkmanG , GranstromL , HammarstromM , MobergerB , et al. Twelve or 24‐hours expectancy in premature rupture of the membranes (PROM) at term. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5‐8; Helsinki, Finland. 1994:408. HjertbergR , HammarstromM , MobergerB , NordlanderE , GranstromL . Premature rupture of the membranes (PROM) at term in nulliparous women with a ripe cervix: a randomized trial of 12 or 24 hours expectant management. Acta Obstetricia et Gynecologica Scandinavica1996;75:48‐53. ">Hjertberg 1996</a>; <a href="./references#CD005302-bbs2-0039" title="HoffmanR , FawcusJ . Oral misoprostol vs. placebo in the management of prelabor rupture of membranes at term. International Journal of Gynecology &amp; Obstetrics2001;72:215‐21. HoffmannR , FawcusS , AnthonyJ . Oral misoprostol versus placebo in the management of prelabour rupture of membranes at term. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. 1999:65. ">Hoffman 2001</a>; <a href="./references#CD005302-bbs2-0040" title="LadforsL , MattssonLA , ErikssonM , FallO . A randomised trial of two expectant managements of prelabour rupture of the membranes at 34 to 42 weeks. British Journal of Obstetrics and Gynaecology1996;103:755‐62. LadforsL , MattssonLA , ErikssonM , FallO . A randomized prospective trial of two expectant managements of pre‐labor rupture of the membranes (PROM) at 34‐42 weeks. American Journal of Obstetrics and Gynecology1994;170:344. LadforsL , TessinI , FallO , EriksonM , MatssonL . A comparison of neonatal infectious outcome comparing two expectant managements of women with prelabor rupture of the membranes at 34‐42 weeks. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S197. ">Ladfors 1996</a>; <a href="./references#CD005302-bbs2-0041" title="LevyR , VaisbuchE , FurmanB , DoitchH , OronS , HagayZ . Prospective randomized clinical trial of immediate induction of labor with oral misoprostol for prelabor rupture of the membranes in women with unfavorable cervix at term [abstract]. American Journal of Obstetrics and Gynecology2005;193(6 Suppl):S44. ">Levy 2005</a>; <a href="./references#CD005302-bbs2-0042" title="LevyR , VaisbuchE , FurmanB , BrownD , VolachV , HagayZJ . Induction of labor with oral misoprostol for premature rupture of membranes at term in women with unfavorable cervix: a randomized, double‐blind, placebo‐controlled trial. Journal of Perinatal Medicine2007;35(2):126‐9. ">Levy 2007</a>; <a href="./references#CD005302-bbs2-0043" title="LoJ , AlexanderJ , McIntireD , LevenoK . Efficacy of oral misoprostol in nulliparous women with premature rupture of membranes [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJY , AlexanderJM , McIntireDD , LevenoKJ . Randomized trial of oral misoprostol in nulliparous women with premature rupture of membranes at term [abstract]. American Journal of Obstetrics and Gynecology2001;185(6 Suppl):S204. LoJY , AlexanderJM , McIntireDD , LevenoKJ . Ruptured membranes at term: randomized, double‐blind trial of oral misoprostol for labor induction. Obstetrics &amp; Gynecology2003;101:685‐9. ">Lo 2003</a>; <a href="./references#CD005302-bbs2-0044" title="MahmoodTA , DickMJW , SmithNC . Management of spontaneous rupture of the membranes and no uterine activity in healthy primigravidae after 34 weeks' gestation. Lancet1989;1:721. ">Mahmood 1989</a>; <a href="./references#CD005302-bbs2-0045" title="CararachV , SentisJ , BotetF , CostaJ , ManauD , ArimanyMC . Cervical prostaglandin E2 compared with expectant management or systematic induction in PROM with bad cervical conditions: I‐maternal results. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5‐8; Helsinki, Finland. 1994. MateosD , CararachV , SentisJ , BotetF , FiguerasF , ArimanyM , et al. Cervical prostaglandin E2 compared with expectant management or systematic induction in premature rupture of the membranes with bad cervical conditions. Prenatal and Neonatal Medicine1998;1(Suppl 1):85. ">Mateos 1998</a>; <a href="./references#CD005302-bbs2-0046" title="McCaulJF , RogersLW , PerryKG , MartinRW , AlbertJR , MorrisonJC . Premature rupture of membranes at term with an unfavorable cervix: comparison of expectant management, vaginal prostaglandin, and oxytocin induction. Southern Medical Journal1997;90(12):1229‐33. McCaulJF , WilliamsLM , MartinRW , MagannEF , GallagherL , MorrisonJC . Comparison of induction methods for premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1992;166(1 Pt 2):275. ">McCaul 1997</a>; <a href="./references#CD005302-bbs2-0047" title="MoralesWJ , LazarAJ . Expectant management of rupture of membranes at term. Southern Medical Journal1986;79(8):955‐8. ">Morales 1986</a>; <a href="./references#CD005302-bbs2-0048" title="NgaiC , ToW , LaoT , HoP . Cervical priming with oral misoprostol in prelabour rupture of membranes at term. 27th British Congress of Obstetrics and Gynaecology;1995 July 4‐7; Dublin. 1995. NgaiSW , ToWK , LaoT , HoPC . Cervical priming with oral misoprostol in pre‐labour rupture of membranes at term. Obstetrics &amp; Gynecology1996;87:923‐6. ">Ngai 1996</a>; <a href="./references#CD005302-bbs2-0049" title="OzdenS , DelikaraMN , AvciA , FiciciogluC . Intravaginal misoprostol vs. expectant management in premature rupture of membranes with low Bishop scores at term. International Journal of Gynecology &amp; Obstetrics2002;77:109‐15. ">Ozden 2002</a>; <a href="./references#CD005302-bbs2-0050" title="Perez PicarolE , GamissansD , LecumberriJ , JimenezM , VernetM . Ripening the cervix with intracervical PGE2 gel in term pregnancies with premature rupture of the membranes. Proceedings of the 12th European Congress of Perinatal Medicine; 1990 September 11‐14; Lyon, France. 1990:197. ">Perez Picarol 1990</a>; <a href="./references#CD005302-bbs2-0051" title="PoornimaB , DharmaDB . Premature rupture of membranes at term: Immediate induction with PGE 2 gel compared with delayed induction with oxytocin. Journal of Obstetrics and Gynecology of India2011;61(5):516‐8. ">Poornima 2011</a>; <a href="./references#CD005302-bbs2-0052" title="RayDA , GariteTJ . Prostaglandin E2 for induction in term patients with premature rupture of the membranes. Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians; 1990 January 23‐27; Houston, Texas, USA. 1990:80. RayDA , GariteTJ . Prostaglandin E2 for induction of labour in patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1992;166:836‐43. ">Ray 1992</a>; <a href="./references#CD005302-bbs2-0053" title="RydhstromH , IngemarssonI . No benefit from conservative management in nulliparous women with premature rupture of the membranes (PROM) at term: a randomized study. Acta Obstetricia et Gynecologica Scandinavica1991;70:543‐7. ">Rydhstrom 1991</a>; <a href="./references#CD005302-bbs2-0054" title="ShettyA , StewartK , StewartG , RiceP , DanielianP , TempletonA . Active management of term prelabour rupture of membranes with oral misoprostol. BJOG: an international journal of obstetrics and gynaecology2002;109:1354‐8. ">Shetty 2002</a>; <a href="./references#CD005302-bbs2-0055" title="ShoaibF . Management of premature rupture of membranes with unfavourable cervix at term, by prostaglandins. Specialist1994;10:227‐32. ">Shoaib 1994</a>; <a href="./references#CD005302-bbs2-0056" title="SuzukiS , OtsuboY , SawaR , YoneyamaY , ArakiT . Clinical trial of induction of labor versus expectant management in twin pregnancy. Gynecologic and Obstetric Investigation2000;49:24‐7. ">Suzuki 2000</a>; <a href="./references#CD005302-bbs2-0057" title="ThomasN , LongoSA , RumneyPJ . Intravaginal misoprostol in prelabour rupture of membranes at term. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S136. ">Thomas 2000</a>; <a href="./references#CD005302-bbs2-0058" title="Van derWaltD , VenterPF . Management of term pregnancy with premature rupture of the membranes and unfavourable cervix. South African Medical Journal1989;75:54‐6. ">Van der Walt 1989</a>; <a href="./references#CD005302-bbs2-0059" title="vanHeerdenJ , SteynDW . Management of premature rupture of membranes after 34 weeks gestation. Proceedings of 11th Conference on Priorities in Perinatal Care in South Africa; 1992; Caledon, South Africa. 1992. vanHeerdenJ , SteynDW . Management of premature rupture of the membranes after 34 weeks' gestation ‐ early versus delayed induction of labour. South African Medical Journal1996;86:264‐8. ">Van Heerden 1992</a>). For further details see: <a href="./references#CD005302-sec-0171" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD005302-sec-0089"> <h3 class="title">Risk of bias in included studies</h3> <p>For summaries of the risk of bias across all included studies see <a href="#CD005302-fig-0002">Figure 2</a> and <a href="#CD005302-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD005302-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005302-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005302-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005302-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD005302-sec-0090"> <h4 class="title">Allocation</h4> <p>Seven of the 23 trials (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>) used adequate methods for sequence generation. Five of the trials generated their random number sequence using a computer, and two (<a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>) used a random number table. </p> <p>In six trials (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>) risk of selection bias (due to inadequate methods to generate a random sequence) was judged to be high: <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>: randomisation was based on choosing two types of cards; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>: a <i>"randomization list"</i> was used to assign odd and even numbers; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a> and <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: randomisation was based on the last digit of the medical record number (odd and even); <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: randomisation was by alternation; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a> randomisation was based on the date of hospital visit. </p> <p>In the remaining 10 trials (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>) methods for random sequence generation (and thus the risk of selection bias) were unclear. </p> <p>Only four of the 23 trials (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>) were judged to be at a low risk of selection bias, employing appropriate methods to conceal allocation. <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a> kept the code with a third party (central randomisation), and <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> used centrally‐controlled computer randomisation, with telephone access. <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a> and <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> used sealed, opaque, sequentially numbered envelopes. </p> <p>Six trials (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>) were quasi‐randomised, and thus the risk of selection bias due to lack of allocation concealment was judged to be high. </p> <p>For the remaining 13 trials, the risk of selection bias due to lack of allocation concealment was judged to be unclear (largely due to inadequate information provided) (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a> ; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>). </p> </section> <section id="CD005302-sec-0091"> <h4 class="title">Blinding</h4> <p>In three trials, women and personnel were blinded throughout by the use of a placebo (<a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>), and thus the risk of performance bias was judged to be low. </p> <p>In the trials that did not use a placebo, it was considered that blinding of women and personnel would not have been possible (though largely, blinding was not discussed), and thus risk of performance bias was judged to be high (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>). Three trials (<a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>) were specifically described as being <i>"open"</i> and <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a> discussed that <i>"women, their companions, and the clinicians caring for them were all aware of group allocation".</i> </p> <p>Eight trials were judged to be at low risk of detection bias. In three trials, blinding was achieved through the use of a placebo (<a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>). In the other five trials, blinding of outcome assessment was described (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>) for at least some outcomes (predominately for the assessment of chorioamnionitis and neonatal infection). </p> <p>In three trials the risk of detection bias in three trials was judged to be high (<a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>) with the trials described as <i>"open".</i> </p> <p>In the remaining 12 trials, the risk of detection bias was judged to be unclear, largely due to no information provided on whether outcome assessments were able to be performed blind (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>). </p> </section> <section id="CD005302-sec-0092"> <h4 class="title">Incomplete outcome data</h4> <p>In eight trials (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>) the risk of attrition bias was judged to be low. In <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>, only one of 34 women in the planned early birth group and one of 33 women in the expectant management group were lost to follow‐up due to missing case records. One woman of 5042 in <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> was lost to follow‐up (data not received); and for the maternal satisfaction outcome, completed questionnaires were obtained from 4129 women (81.9%). In <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>, 4% of women (10/230, five from each group) were excluded from the final analysis, as they did not fulfil the study criteria. <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a> reported that only one woman (of 76) was lost to follow‐up. In <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>, three of 51 women in the planned early birth group and two of 55 in the expectant management group, were excluded following randomisation. In <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> and <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>, there were no losses or exclusions. </p> <p>The remaining 15 trials were judged to be at an unclear risk of attrition bias, mostly with no (or limited) information reported on losses or missing data (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>). </p> </section> <section id="CD005302-sec-0093"> <h4 class="title">Selective reporting</h4> <p>Only five of the 23 trials were judged to be at low risk of reporting bias (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>). </p> <p>The risk of reporting bias was judged to be high in seven trials. In <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>, data for very few outcomes were reported; for some outcomes (e.g. interval between PROM and birth), only mean values were reported, and other outcomes were only mentioned in the manuscript Discussion (e.g. uterine rupture). In <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>, a number of outcomes that would be expected to be reported (including outcomes described in the abstract and/or methods of the manuscript, such as mean latency and maternal satisfaction) were not. In <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>, for many of the reported outcomes, the numbers of women in each group were unclear, or data were not reported separately for the two study groups. Further, for the outcomes chorioamnionitis and postpartum fever, only percentages were provided per group. In <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>, only percentages were reported for some outcomes in the text (and for caesarean section it was unclear as to which groups of women these percentages related to); the outcome endometritis was only mentioned in the abstract, with no data reported in text. <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a> did not report on a number of outcomes that would be expected, results were reported incompletely for key outcomes (such as maternal and neonatal infection: <i>"not statistically significant"</i>; and no measures of variance reported for others, such as interval between PROM and birth). In <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>, for many outcomes (such as birthweight and Apgar scores) results were reported incompletely (<i>"no differences between groups"</i>). In <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>, there were discrepancies between data in the abstract and text (likely typographical errors); some results were also reported incompletely in text (such as regarding neonatal infection and admission to the nursery). </p> <p>In <a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a> the risk of reporting bias was unclear; the primary outcome pre‐defined in the Methods was definite or probable neonatal infection, however results were reported only for <i>"neonatal antibiotics".</i> Similarly, the risk of reporting bias was judged to be unclear in <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>, with median values only reported for the outcome time from PROM to birth. In a further nine trials, the risk of reporting bias was judged to be unclear due to insufficient information available to confidently determine risk (<a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>). </p> </section> <section id="CD005302-sec-0094"> <h4 class="title">Other potential sources of bias</h4> <p>There was no other obvious source of bias in four trials (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>). </p> <p>Five trials were judged to be at unclear risk of other bias: <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: there was a possible imbalance in the proportions of women who were nulliparous between groups (28/30 versus 21/29 women in the planned versus expectant management groups respectively) (though the authors report <i>"There was no significant differences between the 2 groups"</i>); <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>: there were possible baseline imbalances between groups (such as for parity: number of pregnancies, 1: 31/75 and 45/75 women in the planned early birth versus. expectant management groups respectively), though the authors state <i>"The two groups were similar with regard to control variables"</i>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>: 23/51 women in the expectant management group (and 15/48 women in the planned early birth group) also received acupuncture during the <i>"active phase"</i>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>: there were unbalanced group numbers (298 versus 268) and few baseline characteristics were reported; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: the group numbers were unbalanced (as women who were not induced after 10 hours of ROM in the planned early birth group were excluded); few baseline characteristics were reported, and the authors noted that women in the expectant management group were slightly younger (<i>"significant difference in age"</i>). </p> <p>A further 14 trials were also judged to be at an unclear risk of other potential sources of bias, mostly due to limited information regarding baseline characteristics provided and/or limited methodological detail (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>). </p> </section> </section> <section id="CD005302-sec-0095"> <h3 class="title" id="CD005302-sec-0095">Effects of interventions</h3> <p>See: <a href="./full#CD005302-tbl-0001"><b>Summary of findings for the main comparison</b> Planned early birth versus expectant management for prelabour rupture of the membranes at term</a> </p> <section id="CD005302-sec-0096"> <h4 class="title">Planned early birth versus expectant management</h4> <section id="CD005302-sec-0097"> <h5 class="title">Primary outcomes (for the mother)</h5> <section id="CD005302-sec-0098"> <h6 class="title">Maternal infectious morbidity (chorioamnionitis and/or endometritis)</h6> <p>There was variable reporting for this review's primary outcome of maternal infectious morbidity (chorioamnionitis and/or endometritis). </p> <p>When we included only those trials reporting specifically on outcomes termed 'chorioamnionitis' or 'endometritis' a clear reduction was observed for the planned early birth group compared with the expectant management group (average risk ratio (RR) 0.49; 95% confidence interval (CI) 0.33 to 0.72; eight trials, 6864 women; Tau² = 0.19; I² = 72%, <i>low‐quality evidence</i>) (<a href="./references#CD005302-fig-0014" title="">Analysis 1.1</a>). We observed substantial statistical heterogeneity for this outcome, and thus a random‐effects model was used. </p> <p>The trials contributing to this meta‐analysis varied in their outcome definitions/descriptions: <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>: Clinical chorioamnionitis: <i>"Fever before or during labor was defined as a temperature 37.5°C on two occasions 1 hour apart or a temperature of 38°C. Other signs of chorioamnionitis were a maternal white‐cell count 20,000 per cubic millimetre or foul‐smelling amniotic fluid"</i>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>: <i>"pathologic diagnosis of chorioamnionitis"</i>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>: chorioamnionitis <i>"diagnosed by clinical signs and symptoms... along with microorganismic invasion of the amniotic cavity from the cultures taken at birth, and histologic evidence of placental inflammation"</i>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>: <i>"clinical signs of chorioamnionitis"</i>; <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: <i>"Endometritis was defined as uterine tenderness and temperature of 38.0°C or higher on two separate occasions 4 hours apart"</i>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: <i>"Clinically diagnosed chorioamnionitis"</i>; <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a> and <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>: <i>"chorioamnionitis".</i> </p> <p>A subgroup analysis, based on initial mode of induction for planned early birth was performed. While the subgroup interaction test indicated a possible effect of mode of induction on this outcome (Chi² = 12.83, P = 0.005, I² = 76.6%), all subgroups (oral misoprostol; sublingual misoprostol; vaginal prostaglandin E2; intravenous oxytocin) showed effects in favour of planned early birth, although a clear reduction in maternal infectious morbidity was seen only for the sublingual misoprostol and intravenous oxytocin subgroups (<a href="./references#CD005302-fig-0014" title="">Analysis 1.1</a>). The data contributing to the sublingual misoprostol subgroup were from only one trial, of 560 women at an overall unclear to high risk of bias; when these data were excluded from the meta‐analysis, the subgroup interaction test was no longer significant. This may suggest that there were no important differences between various modes of induction on maternal infectious morbidity. </p> <p>We also conducted a meta‐analysis for this outcome including those trials that reported on intrapartum pyrexia and/or treatment with antibiotics for intrapartum pyrexia (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>: "Fever...during labour was defined as a temperature &gt; 37.5°C on 2 occasions 2 1 hour apart or a temperature of &gt; 38°C."; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>: <i>"Pyrexia"</i>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: <i>"fever (&gt; 37.5 "C) in the intrapartum period"</i>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>: <i>"Fever"</i>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a> and <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>: <i>"pyrexia if maternal temperature exceeded 37.5"C in labour"</i>). </p> <p>When these data were included, a reduction in maternal infectious morbidity was also observed in favour of planned early birth (average RR 0.54; 95% CI 0.38 to 0.76; 14 trials, 7667 women; Tau² = 0.19; I² = 62%) (<a href="./references#CD005302-fig-0020" title="">Analysis 1.7</a>). Similarly in this meta‐analysis, the subgroup analysis test indicated a possible treatment effect according to mode of induction (Chi² = 16.58, P = 0.0009, I² = 81.9%), with significant benefits seen only for the oral and sublingual misoprostol and intravenous oxytocin subgroups (<a href="./references#CD005302-fig-0020" title="">Analysis 1.7</a>). The data contributing to the sublingual misoprostol subgroup were from only one trial, of 560 women, at an overall unclear to high risk of bias; when these data were excluded from the meta‐analysis, the subgroup interaction test was no longer significant, again suggesting that there were no important differences between various modes of induction on maternal infectious morbidity defined in this way. </p> <p>We ran a funnel plot to assess the risk of reporting bias, such as publication bias, and we found that while studies were equally distributed on either side, there was some asymmetry, which could represent the presence of bias due to smaller studies (such as <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a> and <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a> (at unclear to high risk of bias) and <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a> (at low risk of bias)) producing exaggerated intervention effect estimates (<a href="#CD005302-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD005302-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.7 Maternal infectious morbidity (chorioamnionitis, endometritis and/or pyrexia)." data-id="CD005302-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.7 Maternal infectious morbidity (chorioamnionitis, endometritis and/or pyrexia). </p> </div> </div> </div> <p>In the above meta‐analyses we did not include the following data.</p> <p> <ul id="CD005302-list-0029"> <li> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported in their abstract that there were fewer women in the misoprostol group with clinical chorioamnionitis <i>"(3% Vs 7.8%)"</i>; it was not clear whether there were any losses to follow‐up or missing data in this trial (and it was thus not possible to accurately/confidently calculate numbers based on these percentages). </p> </li> <li> <p><a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> reported in their discussion that <i>"With regard to maternal postpartum follow up, results were also extremely favourable in both groups with minimal rates of puerperal infection, requirement for antibiotic therapy and other complications".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a> reported that 2/50 and 2/50 women in the planned early birth and expectant management groups respectively had caesarean sections for <i>"nonprogress of labor with chorioamnionitis;"</i> however it was unclear whether there were additional cases of chorioamnionitis among women in the trial. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a> reported that there were 0/72 and 2/80 cases of antepartum pyrexia in the planned early birth and expectant management groups, respectively. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a> reported that <i>"The only clinical infections also occurred in [the expectant management group], 1 mother and 2 babies in all".</i> </p> </li> </ul> </p> </section> <section id="CD005302-sec-0099"> <h6 class="title">Caesarean section</h6> <p>Overall, no clear difference in the risk of caesarean section birth was observed between the planned early birth and expectant management groups (average RR 0.84; 95% CI 0.69 to 1.04; 23 trials, 8576 women; Tau² = 0.10; I² = 55%, <i>low‐quality evidence</i>) (<a href="./references#CD005302-fig-0016" title="">Analysis 1.3</a>). Substantial statistical heterogeneity was observed for this outcome and thus a random‐effects meta‐analysis was used. </p> <p>We ran a funnel plot to assess the risk of reporting bias, and we found that studies were equally distributed on either side, with no substantial asymmetry observed (<a href="#CD005302-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD005302-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.3 Caesarean section." data-id="CD005302-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.3 Caesarean section. </p> </div> </div> </div> <p>A subgroup analysis, based on initial mode of induction for planned early birth was performed. The subgroup interaction test indicated a possible effect of mode of induction on this outcome (Chi² = 25.30, P = 0.0003, I² = 76.3%). The only subgroup to show a significant reduction in the risk of caesarean section was the sublingual misoprostol subgroup (RR 0.54; 95% CI 0.45 to 0.66), however these data were from only one trial, of 560 women, at an overall unclear to high risk of bias (<a href="./references#CD005302-fig-0016" title="">Analysis 1.3</a>). </p> <p><a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a> reported that<i>"The rate of caesarean births in the induction and expectant management groups and those patients who refused to participate in the study group was also similar and not statistically different, ranging between 12.6% and 13.8%".</i> While it was somewhat unclear as to whether these percentages related to the planned early birth and expectant management groups, or the group of women that refused to participate; these data have been included in the meta‐analysis. </p> </section> <section id="CD005302-sec-0100"> <h6 class="title">Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit) </h6> <p>Only three of the 23 trials (425 women) reported data on this outcome (<a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>). <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> reported that there were no maternal deaths or serious complications in either group; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a> indicated that there were no maternal deaths, <i>"All mothers and infants were well at follow up six weeks after delivery"</i>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a> reported that there were no maternal deaths in either group (<a href="./references#CD005302-fig-0017" title="">Analysis 1.4</a>). We assessed this outcome to be of <i>very low‐quality evidence</i>. </p> </section> </section> <section id="CD005302-sec-0101"> <h5 class="title">Primary outcomes (for the fetus/neonate)</h5> <section id="CD005302-sec-0102"> <h6 class="title">Definite early‐onset neonatal sepsis</h6> <p>Only six trials contributed data to the outcome definite early‐onset neonatal sepsis, and overall, no clear difference between the planned early birth and expectant management groups was shown (RR 0.57; 95% CI 0.24 to 1.33; six trials, 1303 infants; <i>very low‐quality evidence</i>) (<a href="./references#CD005302-fig-0018" title="">Analysis 1.5</a>). </p> <p>A subgroup analysis, based on initial mode of induction for planned early birth was performed for this outcome, with the interaction test indicating no clear subgroup differences (Chi² = 0.04, P = 0.84, I² = 0%) (<a href="./references#CD005302-fig-0018" title="">Analysis 1.5</a>). </p> <p>The trials contributing to this meta‐analysis varied in their outcome definitions/descriptions: <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: <i>"proven neonatal infection"</i>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>: <i>"positive bacteriological screen"</i>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>: "<i>Documented neonatal sepsis (positive blood culture or cerebrospinal fluid</i>"; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>: <i>"Positive bacterial cultures"</i>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>: neonates who <i>"developed pyrexia and were given broad spectrum Antibiotics but cultures were negative";</i> and <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: <i>"Documented neonatal infection requiring a full course of antibiotics".</i> </p> </section> <section id="CD005302-sec-0103"> <h6 class="title">Definite or probable early‐onset neonatal sepsis</h6> <p>Overall, a reduction in the risk of definite or probable early‐onset neonatal sepsis was observed (RR 0.73; 95% CI 0.58 to 0.92; 16 trials, 7314 infants, <i>low‐quality evidence</i>) (<a href="./references#CD005302-fig-0019" title="">Analysis 1.6</a>). </p> <p>A subgroup analysis, based on initial mode of induction for planned early birth was performed for this outcome, with the interaction test indicating no clear subgroup differences (Chi² = 2.66, P = 0.26, I² = 24.9%) (<a href="./references#CD005302-fig-0019" title="">Analysis 1.6</a>). </p> <p>We ran a funnel plot to assess the risk of reporting bias, but we did not find pronounced asymmetry (<a href="#CD005302-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD005302-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.6 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.6 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> </div> <p>The trials contributing to this meta‐analysis varied in their outcome definitions/descriptions: <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> reported a composite outcome of definite or probable neonatal infection and did not report definite and probable infection separately: <i>"Definite neonatal infection was defined as the presence of clinical signs of infection and one or more of the following: a positive culture of blood, cerebrospinal fluid, urine, tracheal aspirate, or lung tissue; a positive Gram’s stain of cerebrospinal fluid; a positive antigen‐detection test with blood, cerebrospinal fluid, or urine; a chest radiograph compatible with pneumonia; or a histologic diagnosis of pneumonia. Probable neonatal infection was defined as the presence of clinical signs of infection and one or more of the following: a high or low blood neutrophil count, a high immature total neutrophil ratio, a high actual immature neutrophil count, or abnormal cerebrospinal fluid findings showing an elevated white‐cell count, a high level of protein, or a low level of glucose".</i><a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>: reported <i>"sepsis"</i> (no further detail); <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>: <i>"documented neonatal sepsis (positive blood culture or cerebrospinal fluid)"</i>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>: <i>"positive bacterial cultures"</i>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>: <i>"cultures... negative";</i><a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>: <i>"antibiotics for infection or pending culture"</i>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>: <i>"Antibiotics administered in neonates"</i>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: <i>"Proven neonatal infection"</i>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>: <i>"Positive bacteriological screen";</i><a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>: <i>"Neonate sepsis"</i> including, conjunctivitis, congenital pneumonia, septicaemia, and clinical sepsis requiring intravenous antibiotics; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a> and <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: not provided or unclear. <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>: neonates <i>"treated with parenteral antibiotics because of suspected infection secondary to prolonged SROM to delivery interval".</i> </p> <p><a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a> reported that <i>"The only clinical infections also occurred in [the expectant management group], 1 mother and 2 babies in all".</i> These data have not been included in the meta‐analysis. </p> </section> <section id="CD005302-sec-0104"> <h6 class="title">Perinatal mortality (stillbirth or neonatal mortality)</h6> <p>No clear difference was observed overall in the risk of perinatal mortality (stillbirth or neonatal mortality) with planned early birth compared with expectant management (RR 0.47; 95% CI 0.13 to 1.66; eight trials, 6392 infants, <i>moderate‐quality evidence</i>) (<a href="./references#CD005302-fig-0015" title="">Analysis 1.2</a>). There were a total of three deaths in the planned early birth group and seven in the expectant management group. The three deaths in the planned management group occurred in <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>, and were as a result of lethal congenital abnormalities; two of the seven deaths in the expectant management group were also related to lethal congenital abnormalities (these two deaths were from <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>). </p> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported that <i>"One baby died of multiple congenital abnormalities that was undiagnosed as patient was unbooked. She was in expectant group of management";</i><a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a> also reported that <i>"There was one perinatal mortality in early induction group which was because of congenital heart disease with early onset septicemia not due to induction complications such as fetal distress or hyper‐stimulation of uterus."</i> In both trials it was unclear whether there were any other deaths, and thus these data were not included in the above meta‐analysis. </p> <p>A subgroup analysis, based on initial mode of induction for planned early birth was performed for this outcome, with the interaction test indicating no clear subgroup differences (Chi² = 0.00, P = 0.95, I² = 0%) (<a href="./references#CD005302-fig-0015" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD005302-sec-0105"> <h5 class="title">Secondary outcomes (for the mother)</h5> <section id="CD005302-sec-0106"> <h6 class="title">Chorioamnionitis (either suspected or proven)</h6> <p>A significant reduction in the risk of chorioamnionitis (either suspected or proven) was observed in the planned early birth group compared with the expectant management group (average RR 0.55; 95% CI 0.37 to 0.82; eight trials, 6874 women; Tau² = 0.19; I² = 73%) (<a href="./references#CD005302-fig-0021" title="">Analysis 1.8</a>). </p> <p>Data from <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a> on the outcome clinical signs of chorioamnionitis were included in the meta‐analysis; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a> also reported that 100/124 placentas were examined histologically <i>"The degree of chorioamnionitis in the LI‐group was higher than that in the EI‐group (p &lt; 0.05)".</i> </p> <p>As above for the outcome maternal infectious morbidity, we also conducted a meta‐analysis including data from the trials reporting on intrapartum pyrexia/fever and/or treatment with antibiotics for intrapartum pyrexia (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>). With inclusion of these data, a significant reduction in chorioamnionitis with planned early birth was also observed (average RR 0.60; 95% CI 0.42 to 0.85; 14 trials, 7677 women; Tau² = 0.18; I² = 62%) (<a href="./references#CD005302-fig-0022" title="">Analysis 1.9</a>). </p> <p>We ran a funnel plot to assess the risk of reporting bias, and we found some asymmetry, which could represent the presence of bias due to smaller studies (such as <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a> and <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>, which were judged to be at unclear to high risk of bias) producing exaggerated intervention effect estimates (<a href="#CD005302-fig-0007">Figure 7</a>). However the overall result is also heavily influenced by the <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> trial. </p> <div class="figure" id="CD005302-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.9 Chorioamnionitis and/or pyrexia (either suspected or proven)." data-id="CD005302-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.9 Chorioamnionitis and/or pyrexia (either suspected or proven). </p> </div> </div> </div> </section> <section id="CD005302-sec-0107"> <h6 class="title">Endometritis</h6> <p>Only one trial (<a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>) clearly reported on the outcome 'endometritis', and although fewer cases were observed with planned early birth (2/86) compared with expectant management (8/86), no clear difference overall was observed (RR 0.25; 95% CI 0.05 to 1.14; one trial, 172 women; <a href="./references#CD005302-fig-0023" title="">Analysis 1.10</a>). </p> <p><a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a> reported in their abstract only that <i>"the clinical diagnosis of postpartum endometritis was not significantly different in the two groups"</i>; however no further data on this outcome were reported. </p> <p><a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a> reported that <i>"four women had postpartum infection....as wound infection, intraamnionic infection, or postpartum endometritis"</i>; from Figure 2 in the manuscript, it could be determined that 1/62 and 3/62 women in the planned early birth and expectant management groups respectively had postpartum infection, however it was not clear how many women had postpartum endometritis. </p> </section> <section id="CD005302-sec-0108"> <h6 class="title">Postpartum pyrexia</h6> <p>No clear difference in the risk of postpartum pyrexia was observed between the planned early birth and expectant management groups (average RR 0.91; 95% CI 0.45 to 1.84; seven trials, 5713 women; Tau² = 0.53; I² = 74%) (<a href="./references#CD005302-fig-0024" title="">Analysis 1.11</a>). </p> <p>The trials contributing to this meta‐analysis varied in their outcome definitions/descriptions: <a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>: <i>"Postpartum fever was defined as a temperature &gt; 38°C"</i>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>: <i>"Postpartum fever was defined as a temperature 38°C"</i>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>: <i>"pyrexia of more than &gt; 38°C... in postpartum period"</i>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>: <i>"Febrile episode puerperium"</i> (&gt; 37.5°C); <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>: <i>"maternal temperature exceeded 37.5"C... within 24 h after delivery"</i>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a> and <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>: not clear. </p> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported in their abstract that there were fewer women in the misoprostol group with postpartum fever <i>"(1% Vs 1.8%)"</i>; it was not clear whether there were any losses to follow‐up or missing data in this trial (and it was thus not possible to accurately/confidently calculate numbers based on these percentages). </p> </section> <section id="CD005302-sec-0109"> <h6 class="title">Postpartum septicaemia</h6> <p>A possible reduction in postpartum sepsis was observed with planned early birth compared with expectant management (RR 0.26; 95% CI 0.07 to 0.96; three trials, 263 women) (<a href="./references#CD005302-fig-0025" title="">Analysis 1.12</a>). The three trials contributing data to this outcome reported on <i>"puerperal sepsis"</i> (<a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>); postpartum sepsis (<a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>) and <i>"maternal... sepsis"</i> (<a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>). </p> </section> <section id="CD005302-sec-0110"> <h6 class="title">Postpartum antibiotic usage</h6> <p>No clear difference in the use of maternal postpartum antibiotics was observed between the planned early birth and expectant management groups (RR 0.69; 95% CI 0.40 to 1.20; four trials, 685 women) (<a href="./references#CD005302-fig-0026" title="">Analysis 1.13</a>). </p> </section> <section id="CD005302-sec-0111"> <h6 class="title">Caesarean section for fetal distress</h6> <p>No clear difference in the risk of caesarean section for fetal distress was observed between the planned early birth and expectant management groups (RR 0.94; 95% CI 0.60 to 1.49; 11 trials, 1851 women) (<a href="./references#CD005302-fig-0027" title="">Analysis 1.14</a>). We ran a funnel plot to assess the risk of reporting bias, and we found that studies were approximately equally distributed on either side, with no substantial asymmetry observed (<a href="#CD005302-fig-0008">Figure 8</a>). </p> <div class="figure" id="CD005302-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.14 Caesarean section for fetal distress." data-id="CD005302-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.14 Caesarean section for fetal distress. </p> </div> </div> </div> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported that <i>"The rate of cesarean section with misoprostol was 24%, caesarean section was done for various indications, but majority i.e. 14% were due to fetal distress. But with expectant management cesarean section was slightly higher i‐e. and indications are mostly other fetal distress that is failure to progress".</i> No further details were provided and thus these data could not be included in the meta‐analysis. </p> </section> <section id="CD005302-sec-0112"> <h6 class="title">Induction of labour</h6> <p>Overall, a significant increase in induction of labour was observed for women in the planned early birth compared with the expectant management group (average RR 3.41; 95% CI 2.87 to 4.06; 12 trials, 6945 women; Tau² = 0.05; I² = 71%) (<a href="./references#CD005302-fig-0028" title="">Analysis 1.15</a>). We ran a funnel plot to assess the risk of reporting bias, and we found that studies were equally distributed on either side, with no substantial asymmetry observed (<a href="#CD005302-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD005302-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.15 Induction of labour." data-id="CD005302-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.15 Induction of labour. </p> </div> </div> </div> </section> <section id="CD005302-sec-0113"> <h6 class="title">Operative vaginal birth</h6> <p>No clear difference in the risk of operative vaginal birth was observed between the planned early birth and expectant management groups (average RR 1.03; 95% CI 0.67 to 1.59; 13 trials, 6379 women; Tau² = 0.25; I² = 56%) (<a href="./references#CD005302-fig-0029" title="">Analysis 1.16</a>). We ran a funnel plot to assess the risk of reporting bias, and we found that studies were approximately equally distributed on either side, with no substantial asymmetry observed (<a href="#CD005302-fig-0010">Figure 10</a>). </p> <div class="figure" id="CD005302-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.16 Operative vaginal birth." data-id="CD005302-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.16 Operative vaginal birth. </p> </div> </div> </div> </section> <section id="CD005302-sec-0114"> <h6 class="title">Uterine rupture</h6> <p>Only two trials reported on uterine rupture, and only one case was observed in the planned early birth group in <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a> (RR 2.90; 95% CI 0.12 to 68.50; two trials, 143 women; <a href="./references#CD005302-fig-0030" title="">Analysis 1.17</a>). <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> also reported that <i>"The frequency of other complications during labor, including... ruptured uterus... was low and did not differ significantly among the groups (data not shown)".</i> </p> </section> <section id="CD005302-sec-0115"> <h6 class="title">Epidural analgesia</h6> <p>No clear difference in the use of epidural analgesia was observed between the planned early birth and expectant management groups (RR 1.07; 95% CI 0.80 to 1.42; five trials, 585 women) (<a href="./references#CD005302-fig-0031" title="">Analysis 1.18</a>). </p> <p><a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a> did not state type of analgesia or anaesthesia (and thus the data have not been included in the meta‐analysis); however it was reported that 33/52 and 42/52 women in the planned early birth group required analgesia and anaesthesia respectively, compared with 60/74 and 58/74 in the expectant management group. </p> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported that <i>"The requirement of analgesia during labour was same in induction and expectant group"</i>; but provided no further details. </p> <p><a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a> reported on the use of pain relief, pethidine and epidural analgesia, which was required for 31/61 (50.8%) in the planned early birth group versus 15/62 (24.2%) in the expectant management group. </p> </section> <section id="CD005302-sec-0116"> <h6 class="title">Postpartum haemorrhage</h6> <p>Only three trials reported on postpartum haemorrhage, and no clear difference was shown between the planned early birth and expectant management groups (RR 0.43; 95% CI 0.14 to 1.28; three trials, 520 women) (<a href="./references#CD005302-fig-0032" title="">Analysis 1.19</a>). </p> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> also reported that <i>"PPH was experienced in 3% of the patients in the study with no difference among the two groups".</i> </p> </section> <section id="CD005302-sec-0117"> <h6 class="title">Adverse effects</h6> <p>Limited and varied data regarding adverse effects associated with the interventions were reported from the included trials, and thus we did not conduct a meta‐analysis for this outcome. </p> <p> <ul id="CD005302-list-0030"> <li> <p>In regards to <i>"complications"</i><a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a> reported that 2/42 women experienced uterine hyperstimulation and 1/42 uterine tachysystole in the planned early birth group, and that 1/42 women experienced nausea and vomiting in the expectant management group. </p> </li> <li> <p>In the translation of <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>, it was stated that <i>"No unpleasant side‐effects were noted".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a> reported that in the planned early birth group 2, 2/33 women had uterine hyperstimulation (both having six contractions in 10 minutes), but no women required administration of tocolytics. </p> </li> <li> <p>In <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>, 1/30 and 2/29 women experienced hyperstimulation in the planned early birth and expectant management group, respectively, 2/30 and 2/29 experienced vomiting. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a> reported that there were no complications for 90/100 women in the planned early birth group and 23/100 in the expectant management group; however no definition was provided for <i>"complications".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> reported that 4/75 and 1/75 women experienced hyperstimulation, 4/75 and 10/75 experienced intralabour deceleration, and 8/75 and 2/75 experienced alterations of contractility (hypercontractility or tachysystoles), in the planned early birth and expectant management groups, respectively. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a> noted that <i>"No adverse effect of acupuncture was reported, except for 1 woman reporting dizziness and discomfort after the first acupuncture treatment, and, therefore, refused another treatment day 2".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> reported that <i>"The frequency of other complications during labor, including vomiting or diarrhea, hypertonus, ruptured uterus, abruptio placentae, and shoulder dystocia, was low and did not differ significantly among the groups (data not shown)".</i> </p> </li> <li> <p><a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a> reported that there were 2/50 and 3/50 women with "maternal morbidity" in the planned early birth group and 23/100 in the expectant management group; in the methods section of the manuscript, it was reported that <i>"Clinical parameters considered for maternal morbidity were fever, tachycardia, abdominal tenderness, foul smelling lochia, subinvolution of uterus, and evaluation of stich</i> (sic)<i>line."</i> </p> </li> </ul> </p> </section> <section id="CD005302-sec-0118"> <h6 class="title">Views of care</h6> <p>Only two trials reported on measures of maternal views of care. <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a> asked women ‘How do you experience your plan of treatment after PROM?’, using a visual analogue scale (0 = very negative; 100 = very positive), and observed that women in the planned management group had a more positive experience compared with women in the expectant management group (mean difference (MD): 11.80 points higher; 95% CI 4.36 to 19.24; 93 women) (<a href="./references#CD005302-fig-0033" title="">Analysis 1.20</a>). <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> observed that fewer women in the planned management group reported that there was nothing about their management that they liked (RR 0.43; 95% CI 0.36 to 0.52; 5041 women) (<a href="./references#CD005302-fig-0034" title="">Analysis 1.21</a>), and more women in the planned management group reported that there was nothing they disliked about their management (RR 1.20; 95% CI 1.10 to 1.30; 5041 women) (<a href="./references#CD005302-fig-0035" title="">Analysis 1.22</a>). </p> </section> <section id="CD005302-sec-0119"> <h6 class="title">Outcomes not reported by the included trials</h6> <p>None of the included trials reported on the following secondary outcomes: breastfeeding, including initiation in hospital and on discharge from hospital; or postnatal depression. </p> </section> </section> <section id="CD005302-sec-0120"> <h5 class="title">Secondary outcomes (for the fetus/neonate)</h5> <section id="CD005302-sec-0121"> <h6 class="title">Time from rupture of membranes (ROM) to birth</h6> <p>Overall, a significant reduction in time from ROM to birth was observed for the planned early birth group compared with the expectant management group (MD ‐10.10 hours; 95% CI ‐12.15 to ‐8.06; nine trials, 1484 women; Tau² = 5.81; I² = 60%) (<a href="./references#CD005302-fig-0036" title="">Analysis 1.23</a>). One of the trials in this meta‐analysis reported on time between recruitment and birth (<a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>), and one reported on time from ROM to onset of labour (<a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>). We ran a funnel plot to assess the risk of reporting bias, and we found that studies were approximately equally distributed on either side, with no asymmetry observed (<a href="#CD005302-fig-0011">Figure 11</a>). </p> <div class="figure" id="CD005302-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.23 Time from rupture of membranes to birth (hours)." data-id="CD005302-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.23 Time from rupture of membranes to birth (hours). </p> </div> </div> </div> <p>Ten other trials (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>) reported data on this outcome that could not be included in the meta‐analysis (e.g. because medians (with 5th and 9th percentiles or ranges) were reported). These data (<a href="./references#CD005302-fig-0037" title="">Analysis 1.24</a>) were found to be consistent with the above meta‐analysis (i.e. showing significant reductions in time from ROM to birth with planned early birth), except for in one trial (<a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a> which assessed acupuncture), where no clear difference between groups in time from ROM to birth was observed. </p> </section> <section id="CD005302-sec-0122"> <h6 class="title">Birthweight</h6> <p>A possible lower birthweight was observed for neonates born to mothers in the planned early birth group compared with the expectant management group (MD ‐79.25 g; 95% CI ‐124.96 to ‐33.55; five trials, 1043 infants) (<a href="./references#CD005302-fig-0038" title="">Analysis 1.25</a>). </p> <p>Two additional trials reported data that could not be included in the meta‐analysis (reporting mean birthweight (and/or range) only) (<a href="./references#CD005302-fig-0039" title="">Analysis 1.26</a>); one trial suggested lower birthweight in the planned early birth group (<a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>), while the other suggested higher birthweight in the planned early birth group (<a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>); neither reported results of test of significance. </p> <p><a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> did not report on birthweight, however reported that 8/75 and 4/75 neonates were born small‐for‐gestational age or large‐for‐gestational age in the planned early birth and expectant management groups, respectively (P = 0.35). <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a> reported that "<i>There were no differences in birthweight… between the two groups".</i> </p> </section> <section id="CD005302-sec-0123"> <h6 class="title">Cord prolapse</h6> <p>No clear difference in risk of cord prolapse was observed between the planned early birth and expectant management groups (RR 0.51; 95% CI 0.09 to 2.75; four trials, 5740 infants) (<a href="./references#CD005302-fig-0040" title="">Analysis 1.27</a>). Two of the four trials included in this meta‐analysis reported specifically on <i>"caesarean for cord prolapse"</i> (<a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>; <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>). </p> </section> <section id="CD005302-sec-0124"> <h6 class="title">Stillbirth</h6> <p>Only three trials reported on stillbirth (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>); there were no stillborn babies in the planned early birth groups of the three trials; in <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>, there were two stillborn babies in the expectant management group (RR 0.20; 95% CI 0.01 to 4.18; three trials, 5314 infants) (<a href="./references#CD005302-fig-0041" title="">Analysis 1.28</a>). These data excluded lethal congenital anomalies. </p> </section> <section id="CD005302-sec-0125"> <h6 class="title">Neonatal mortality</h6> <p>Seven trials reported on neonatal mortality. There were no neonatal deaths in the planned early birth groups of the seven trials; in <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>, there were two neonatal deaths in the expectant management group (RR 0.20; 95% CI 0.01 to 4.18; seven trials, 6352 neonates) (<a href="./references#CD005302-fig-0042" title="">Analysis 1.29</a>). These data excluded lethal congenital anomalies. </p> </section> <section id="CD005302-sec-0126"> <h6 class="title">Pneumonia</h6> <p>Only two trials reported specifically on neonatal pneumonia, and showed no clear difference between the planned early birth and expectant management groups (RR 0.62; 95% CI 0.04 to 9.09; two trials, 280 infants) (<a href="./references#CD005302-fig-0043" title="">Analysis 1.30</a>). </p> </section> <section id="CD005302-sec-0127"> <h6 class="title">Antibiotic usage</h6> <p>Significantly fewer neonates in the planned management group compared with the expectant management group received antibiotics (average RR 0.61; 95% CI 0.44 to 0.84; 10 trials, 6427 infants; Tau² = 0.06; I² = 32%) (<a href="./references#CD005302-fig-0044" title="">Analysis 1.31</a>). We ran a funnel plot to assess the risk of reporting bias, and we found some asymmetry, which could represent the presence of bias due to smaller studies (such as <a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>, <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a> and <a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>, which were judged to be at unclear to high risk of bias) producing exaggerated intervention effect estimates (<a href="#CD005302-fig-0012">Figure 12</a>). However, the overall result is also heavily influenced by the <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> trial. </p> <div class="figure" id="CD005302-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.31 Antibiotic usage." data-id="CD005302-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.31 Antibiotic usage. </p> </div> </div> </div> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported that <i>"Only 2% of babies delivered had A/S &lt; 5 at 5 minutes and required active resuscitation and required admission in nursery. They remained oxygen dependent for 5‐7 days. Antibiotics were given but cultures were negative"</i> ; <i>"Remaining babies have average A/S between 7 &amp; 9 at 5 minutes 20% were admitted in nursery to tachypnea and given antibiotics for 5 days"; and that "requirement of antibiotics were comparable".</i> It was not possible to include these data in the meta‐analysis. </p> <p><a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a> also reported on neonatal antibiotic use, however it was not clear whether the text provided described all neonates who received antibiotics (or only a subset) and thus these data have not been included in the meta‐analysis. It was reported that of the 2/62 women in the expectant management group who developed clinical signs of chorioamnionitis, one of the neonates was treated with antibiotics because of fever and tachypnoea (the bacterial cultures were negative), and the other showed no signs of infection and received no antibiotics (<a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>). The characteristics of the seven neonates (2/62 and 5/62 in the planned early birth versus expectant management groups, respectively) who were transferred to the paediatric department were also provided, however it was not always clear which group the neonates were from, and/or whether antibiotics were administered. "<i>One infant. whose mother was an EI primipara, had subarachnoid bleeding and hydro‐cephalus, was treated with antibiotics and aspiration of the hematoma, and survived... Another infant was delivered by cesarean section because of signs of intraamniotic infection... A third infant was delivered vaginally 29 hours after the membranes had ruptured... Perinatally the infant was suspected of having septicemia and was treated with antibiotics. The bacterial cultures, however, were all negative. The remaining four infants were transferred because of hyperbilirubinemia... None of the newborns had positive bacterial cultures"</i> (<a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>). </p> </section> <section id="CD005302-sec-0128"> <h6 class="title">Apgar score less than seven at five minutes</h6> <p>No clear difference was observed for Apgar score less than seven at five minutes between the planned early birth and expectant management groups (RR 1.07; 95% CI 0.77 to 1.48; 15 trials, 7175 infants) (<a href="./references#CD005302-fig-0045" title="">Analysis 1.32</a>). We ran a funnel plot to assess the risk of reporting bias, and we found that studies were equally distributed on either side, with no substantial asymmetry observed (<a href="#CD005302-fig-0013">Figure 13</a>). </p> <div class="figure" id="CD005302-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.32 Apgar score less than seven at five minutes." data-id="CD005302-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.32 Apgar score less than seven at five minutes. </p> </div> </div> </div> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported that <i>"Only 2% of babies delivered had A/S &lt; 5 at 5 minutes... The outcome was comparable in both induction as well as expectant group".</i> No further details were provided. </p> </section> <section id="CD005302-sec-0129"> <h6 class="title">Use of mechanical ventilation</h6> <p>Only two trials reported on the need for mechanical ventilation, and showed no clear difference between planned early birth and expectant management groups (average RR 0.90; 95% CI 0.33 to 2.47; two trials, 5158 infants; Tau² = 0.36; I² = 66%) (<a href="./references#CD005302-fig-0046" title="">Analysis 1.33</a>). </p> </section> <section id="CD005302-sec-0130"> <h6 class="title">Abnormality on cerebral ultrasound (cystic periventricular leukomalacia; intraventricular haemorrhage) </h6> <p><a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> reported that no neonates in either group had cerebral haemorrhage (<a href="./references#CD005302-fig-0047" title="">Analysis 1.34</a>). </p> </section> <section id="CD005302-sec-0131"> <h6 class="title">Outcomes not reported by the included trials</h6> <p>None of the included trials reported on the following secondary outcomes: gestational age at birth; meningitis; respiratory distress syndrome; necrotising enterocolitis; neonatal encephalopathy; disability at of childhood follow‐up. <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a> reported on <i>"neonatal morbidity"</i> (a non pre‐specified outcome) (<i>"considered in cases of neonatal septicemia, convulsions, or with birth asphyxia"</i>) for 3/50 and 3/50 infants in the planned early birth and expectant management groups respectively. </p> </section> </section> <section id="CD005302-sec-0132"> <h5 class="title">Secondary outcomes (use of health services)</h5> <section id="CD005302-sec-0133"> <h6 class="title">Duration of maternal antenatal or postnatal stay in hospital</h6> <p>Two trials reported on length of maternal hospitalisation (admission to discharge time (<a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>);<i>"Length of maternal hospitalization"</i> (<a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>)). A significant reduction in length of hospitalisation was observed for the planned early birth group compared with the expectant management group (MD: ‐0.79 days; 95% CI ‐1.20 to ‐0.38; two trials, 748 women; Tau² = 0.05; I² = 59%) (<a href="./references#CD005302-fig-0048" title="">Analysis 1.35</a>). </p> <p>Four other trials reported relevant data that could not be included in the meta‐analysis (e.g. reported medians (5th, 95th percentiles only) (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>). Data from these trials were shown to be mostly consistent with the above meta‐analysis (i.e. showing significantly shorter maternal hospitalisation with planned early birth) (<a href="./references#CD005302-fig-0049" title="">Analysis 1.36</a>). </p> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> reported that women in the misoprostol group had a <i>"shorter period of hospitalization".</i> </p> </section> <section id="CD005302-sec-0134"> <h6 class="title">Admission to neonatal special or intensive care unit</h6> <p>A significant reduction in the risk of admission to the neonatal special or intensive care unit was observed with planned early birth compared with expectant management (RR 0.75; 95% CI 0.66 to 0.85; eight trials, 6179 infants) (<a href="./references#CD005302-fig-0050" title="">Analysis 1.37</a>). </p> <p><a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a> that <i>"Neonatal admissions were 20% in our study,"</i> and that <i>"No significant difference was observed in neonatal morbidity and nursery admission between both groups".</i> </p> </section> <section id="CD005302-sec-0135"> <h6 class="title">Duration of neonatal stay in hospital</h6> <p><a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a> reported on duration of neonatal hospitalisation, and observed a shorter duration for neonates born to mothers in the planned early birth group compared with expectant management group (MD ‐11.00 hours; 95% CI ‐21.96 to ‐0.04; 182 infants) (<a href="./references#CD005302-fig-0051" title="">Analysis 1.38</a>). </p> <p><a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a> reported on <i>"Neonatal stay &gt;3 days",</i> which occurred in 2/75 (2.6%) and 5/75 (6.7%) neonates in the planned early birth versus expectant management groups respectively (P = 0.44). </p> <p><a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> reported on stay in the postpartum ward, with data reported as medians and 5th, 95th percentiles: induction oxytocin group: 62.97 hours (22.40, 130.78) (N = 1258) versus induction prostaglandin group: 62.50 hours (20.03, 136.88) (N = 1259) versus expectant oxytocin group: 63.02 hours (23.05, 137.18) (N = 1263) versus expectant prostaglandin group: 62.97 hours (23.03, 134.22) (N = 1261). </p> </section> <section id="CD005302-sec-0136"> <h6 class="title">Neonatal stay in special or intensive care unit</h6> <p>A significantly shorter duration of neonatal stay in special or intensive care unit was observed for neonates born to mothers in the planned early birth group (RR 0.72; 95% CI 0.61 to 0.85; four trials, 5691 infants) (<a href="./references#CD005302-fig-0052" title="">Analysis 1.39</a>). We combined in a meta‐analysis the following outcomes: <a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a> and <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> reported on stay in the neonatal intensive care unit of more than 24 hours; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a> reported on stay in special care baby unit 25 to 48 hours and 49 hours; and <a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a> reported on <i>"Treatment at neonatal ward &gt; 7 days".</i> </p> </section> </section> <section id="CD005302-sec-0137"> <h5 class="title">Subgroup analyses</h5> <p>The subgroup analyses for method of induction have been integrated into the main structure of the graphs and comments relating to these subgroups have been made above, throughout the main analysis of primary outcomes. </p> <section id="CD005302-sec-0138"> <h6 class="title">Parity</h6> <p>We conducted subgroup analyses based on parity (comparing outcomes for studies including nulliparous women with those including multiparous women and those including both nulliparous and multiparous women). We did not observe any clear subgroup differences based on parity for any of our primary outcomes: maternal infectious morbidity (Chi² = 1.65, P = 0.44, I² = 0%) (<a href="./references#CD005302-fig-0053" title="">Analysis 2.1</a>); caesarean section (Chi² = 2.47, P = 0.29, I² = 19.0%) (<a href="./references#CD005302-fig-0054" title="">Analysis 2.2</a>); definite early‐onset neonatal infection (Chi² = 0.04, P = 0.84, I² = 0%) (<a href="./references#CD005302-fig-0055" title="">Analysis 2.3</a>); definite or probable early‐onset neonatal infection (Chi² = 1.22, P = 0.54, I² = 0%) (<a href="./references#CD005302-fig-0056" title="">Analysis 2.4</a>); or perinatal mortality (test for subgroup differences: not applicable) (<a href="./references#CD005302-fig-0057" title="">Analysis 2.5</a>). Similarly, no clear subgroup differences were observed for these outcomes when we excluded the mixed 'nulliparous and multiparous women' subgroup from these analyses. </p> </section> <section id="CD005302-sec-0139"> <h6 class="title">Cervical status</h6> <p>We conducted subgroup analyses based on cervical status at baseline (comparing outcomes for studies including women with unfavourable cervices only with those including women with both favourable and unfavourable cervices, and those where cervical status was not clear). We did not observe any clear subgroup differences based on cervical status for any of our primary outcomes: maternal infectious morbidity (Chi² = 2.93, P = 0.23, I² = 31.7%) (<a href="./references#CD005302-fig-0058" title="">Analysis 3.1</a>); caesarean section (Chi² = 0.61, P = 0.74, I² = 0%) (<a href="./references#CD005302-fig-0059" title="">Analysis 3.2</a>); definite early‐onset neonatal infection (Chi² = 1.92, P = 0.38, I² = 0%) (<a href="./references#CD005302-fig-0060" title="">Analysis 3.3</a>); definite or probable early‐onset neonatal infection (Chi² = 3.00, P = 0.22, I² = 33.4%) (<a href="./references#CD005302-fig-0061" title="">Analysis 3.4</a>); or perinatal mortality (Chi² = 0.05, P = 0.82, I² = 0%) (<a href="./references#CD005302-fig-0062" title="">Analysis 3.5</a>). </p> <p>Similarly, no clear subgroup differences were observed for these outcomes when we excluded the 'cervical status: not clear' subgroup from these analyses. </p> </section> <section id="CD005302-sec-0140"> <h6 class="title">Maternal antibiotic prophylaxis</h6> <p>We conducted subgroup analyses based on maternal antibiotic prophylaxis (comparing outcomes for studies where all women, some women, or no women received prophylaxis for PROM (or where it was unclear/not stated). The test for subgroup differences for the outcome maternal infectious morbidity was significant (Chi² = 16.19, P = 0.001, I² = 81.5%), indicating a possible differential effect based on use of antibiotic prophylaxis (<a href="./references#CD005302-fig-0063" title="">Analysis 4.1</a>). A significant benefit in favour of planned early birth was shown in the 'all women' subgroup; while no clear differences were observed for the other subgroups. When we excluded the subgroup 'not clear' from the analysis, however, the test for subgroup differences was no longer significant (Chi² = 0.70, P = 0.70, I² = 0%). </p> <p>No clear subgroup differences were shown for the outcomes: caesarean section (Chi² = 1.11, P = 0.77, I² = 0%) (<a href="./references#CD005302-fig-0064" title="">Analysis 4.2</a>); definite early‐onset sepsis (Chi² = 0.04, P = 0.84, I² = 0%) (<a href="./references#CD005302-fig-0065" title="">Analysis 4.3</a>); definite or probable early‐onset sepsis (Chi² = 1.02, P = 0.60, I² = 0%) (<a href="./references#CD005302-fig-0066" title="">Analysis 4.4</a>); or perinatal mortality (Chi² = 0.05, P = 0.82, I² = 0%) (<a href="./references#CD005302-fig-0067" title="">Analysis 4.5</a>). For these outcomes, this was also the case when we excluded the 'routine antibiotic prophylaxis: not clear' subgroup from the analyses. </p> </section> <section id="CD005302-sec-0141"> <h6 class="title">Digital vaginal examination</h6> <p>We conducted subgroup analyses based on whether women received digital vaginal examination at baseline (comparing outcome for studies where all women, some women, or no women received digital vaginal examination (or where it was unclear/not stated). The test for subgroup differences for the outcome maternal infectious morbidity was significant (Chi² = 9.05, P = 0.03, I² = 66.9%), indicating a possible differential effect based on receipt of digital vaginal examination (<a href="./references#CD005302-fig-0068" title="">Analysis 5.1</a>). A significant benefit in favour of planned early birth was shown for the 'all women' and 'not clear' subgroups; while no clear differences were observed for the other subgroups. When we excluded the subgroup 'not clear' from the analysis, however, the test for subgroup differences was no longer significant (Chi² = 0.05, P = 0.982, I² = 0%). </p> <p>Similarly, for the outcome caesarean section (<a href="./references#CD005302-fig-0069" title="">Analysis 5.2</a>), the subgroup interaction test was significant (Chi² = 16.14, P = 0.001, I² = 81.4%), though the only subgroup to show a significant benefit in favour of planned early birth was the 'not clear' subgroup, and when we excluded this subgroup from the analysis, the interaction test no longer suggested a clear difference (Chi² = 0.77, P = 0.68, I² = 0%). </p> <p>No clear subgroup differences were shown for the outcomes: definite early‐onset sepsis (Chi² = 1.92, P = 0.38, I² = 0%) (<a href="./references#CD005302-fig-0070" title="">Analysis 5.3</a>); definite or probable early‐onset sepsis (Chi² = 0.67, P = 0.71, I² = 0%) (<a href="./references#CD005302-fig-0071" title="">Analysis 5.4</a>); or perinatal mortality (Chi² = 0.05, P = 0.82, I² = 0%) (<a href="./references#CD005302-fig-0072" title="">Analysis 5.5</a>). For these outcomes, this was also the case when we excluded the 'digital vaginal examination: not clear' subgroup from the analyses. </p> </section> </section> <section id="CD005302-sec-0142"> <h5 class="title">Sensitivity analysis based on trial quality</h5> <p>A sensitivity analysis based on trial quality was performed for the primary outcomes, by omitting all trials at high or unclear risk of selection bias (considering both allocation concealment and random sequence generation), and trials at high or unclear risk of detection bias. Only three trials contributed data to the sensitivity analyses (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>). </p> <p>Results of the sensitivity analysis were consistent with those of the main analysis, with a reduction in maternal infectious morbidity observed with planned early birth compared with expectant management RR 0.62; 95% CI 0.50 to 0.76; one trial, 5041 women) (<a href="./references#CD005302-fig-0073" title="">Analysis 6.1</a>), and no clear differences between groups for the other outcomes; caesarean section (RR 0.96; 95% CI 0.81 to 1.12; three trials, 5198 women) (<a href="./references#CD005302-fig-0074" title="">Analysis 6.2</a>); definite early‐onset neonatal sepsis (no events; one trial, 59 infants) (<a href="./references#CD005302-fig-0075" title="">Analysis 6.3</a>); definite or probable early‐onset neonatal sepsis (RR 0.91; 95% CI 0.66 to 1.27; three trials, 5198 infants) (<a href="./references#CD005302-fig-0076" title="">Analysis 6.4</a>); and perinatal mortality (RR 0.50; 95% CI 0.13 to 2.00; one trial, 5041 infants) (<a href="./references#CD005302-fig-0077" title="">Analysis 6.5</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005302-sec-0143" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005302-sec-0143"></div> <section id="CD005302-sec-0144"> <h3 class="title" id="CD005302-sec-0144">Summary of main results</h3> <p>This review included 23 randomised controlled trials (involving 8615 women and their babies; including the large <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a> trial of 5042 women) assessing planned early birth, compared with expectant management for prelabour rupture of membranes (PROM) at term. On meta‐analysis, we observed a reduction in the risk of maternal infectious morbidity (chorioamnionitis and/or endometritis) (eight trials, 6864 women) for women in the planned early birth group; the absolute risk reduction was 5.01% (from 11.02% (377/3422) in the expectant management group to 6.01% (207/3442) in the planned early birth group). We also observed a reduction in the risk of definite or probable early‐onset neonatal sepsis (from 4.10% (149/3637) in the expectant management group to 2.99% (110/3677) in the planned early birth group. We did not observe any clear differences between the planned early birth and expectant management groups when considering the other primary outcomes of caesarean section, serious maternal morbidity or mortality (no events in the three trials reporting on this outcome), definite early‐onset neonatal sepsis, or perinatal mortality (stillbirth and/or neonatal death). </p> <p>Similarly, we did not observe clear differences between groups for many of the secondary review outcomes, including the maternal outcomes: endometritis; postpartum pyrexia; postpartum antibiotic usage; caesarean section for fetal distress; operative vaginal birth; uterine rupture; epidural analgesia; and postpartum haemorrhage; and the fetal/neonatal outcomes: cord prolapse; stillbirth; neonatal mortality; pneumonia; Apgar score less than seven at five minutes; use of mechanical ventilation; and abnormality on cerebral ultrasound. </p> <p>We did, however, observe significant reductions with planned early birth in the risk of chorioamnionitis (either suspected or proven) (eight trials, 6874 women), postpartum septicaemia (three trials, 263 women), and neonatal antibiotic usage (10 trials, 6427 infants). In relation to the use of health services, women in the planned early birth group, compared with the expectant management group had a shorter length of hospitalisation, of 0.79 days on average (two trials, 748 women); their neonates also were less likely to be admitted to the neonatal special or intensive care unit (eight trials, 6179 infants), and were more likely to have a shorter neonatal stay in hospital of 11 hours on average (one trial, 182 infants), and a shorter stay in the special or intensive care unit (four trials, 5691 infants). </p> <p>Women who had a planned early birth also viewed their care more favourably in two trials (93 women (<a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>); and 5041 women (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>)). In <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>, women rated their PROM management more positively in the planned early birth group; in <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>, fewer women in the planned early birth group disliked aspects of their management. While these findings are from single studies, they are valuable (particularly the results from <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>, which was a large, high‐quality trial), and contribute to the understanding of women's preferences. </p> <p>As may have been expected, women in the planned early birth group were over three times more likely to have their labour induced (12 trials, 6945 women) and had a shorter duration of rupture of membranes (ROM) to birth, on average of 10 hours (nine trials, 1484 women). Babies born to women in the planned early birth group weighed, on average, 79 g less (five trials 1043 infants). </p> <p>No information was available from the 23 included trials on the maternal outcomes: breastfeeding and postnatal depression; and fetal/neonatal outcomes: gestational age at birth; meningitis; respiratory distress syndrome; necrotising enterocolitis; neonatal encephalopathy. No trial reported on disability at childhood follow‐up. </p> <p>There was substantial heterogeneity for some outcomes. The subgroup analyses (based on initial method of induction, parity, cervical status, antibiotic prophylaxis, digital vaginal examination) and sensitivity analyses (based on trial quality) performed in this review, however largely revealed no clear differential treatment effects according to characteristics of the women or trials. The different methods of outcome measurement and definitions, particularly for review outcomes relating to maternal and neonatal infection, also likely contributed to the heterogeneity observed. </p> <p>Considering the mode of induction of labour, no clear subgroup differences were seen for definite early‐onset neonatal sepsis, definite or probable early‐onset neonatal sepsis or perinatal mortality, and we could not conduct a subgroup analysis for serious maternal morbidity or mortality (with no events occurring). While the subgroup analyses for maternal infectious morbidity and caesarean section suggested possible differential treatment effects (for maternal infectious morbidity: with a significant benefit seen only for the intravenous oxytocin and sublingual misoprostol subgroups; and for caesarean section: with a significant reduction seen for the sublingual misoprostol subgroup), no clear conclusions can be based on these data; the sublingual misoprostol subgroup included data from only one trial (560 women; unclear to high risk of bias) (<a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>), and when this subgroup was removed from the analyses, the interaction tests were no longer significant. Considering the subgroup analyses based on parity, cervical status, maternal antibiotic prophylaxis and digital vaginal examination, largely no differential effects were observed for any of the primary outcomes. Where we did observe possible differential effects (interaction tests were significant), these were mostly not sustained when the mixed/unclear subgroups were removed from analyses; thus the poor reporting or limited methodological detail provided by many of the included studies limited our ability to assess subgroup effects. </p> <p>The sensitivity analyses, including only those high‐quality trials (judged at low risk of selection and detection bias) (including only three trials: <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>) revealed similar findings to the main analysis ‐ a reduction in maternal infectious morbidity (chorioamnionitis and/or endometritis) with planned early birth, and no clear differences between groups for the other primary outcomes. </p> </section> <section id="CD005302-sec-0145"> <h3 class="title" id="CD005302-sec-0145">Overall completeness and applicability of evidence</h3> <p>Although 23 trials were able to be included in this review, over 30 other studies were excluded, and some of these may have had relevant data. Most of these trials reported outcomes for women less than, as well as more than, 37 weeks' gestation at PROM and it was not possible to extract only the information relating to women 37 weeks' gestation or later at PROM; nor were trial authors able to provide this information when it was requested from them. This strict inclusion criterion was applied because women at full term may represent a different clinical group than women with PROM at less than 37 weeks' gestation (which is the topic of another Cochrane review (<a href="./references#CD005302-bbs2-0062" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735] ">Buchanan 2010</a>)). </p> <p>Many important outcomes were not assessed at all by the included trials (including breastfeeding; postnatal depression; gestational age at birth; meningitis; respiratory distress syndrome; necrotising enterocolitis; neonatal encephalopathy; and disability at childhood follow‐up). While all 23 included trials reported on caesarean section, many did not report on the other primary outcomes (for example, with only three trials reporting on serious maternal morbidity or mortality), and for a number of secondary outcomes (such as endometritis; uterine rupture; views of care; neonatal pneumonia; use of mechanical ventilation; and abnormality on cerebral ultrasound), only one or two trials contributed outcome data for the meta‐analyses. </p> <p>The included trials were conducted in China (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>), Scotland (<a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>), Brazil (<a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>), Canada (<a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>), Denmark (<a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>), Germany (<a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>), India (<a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>), Norway (<a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>), Pakistan (<a href="./references#CD005302-bbs2-0002" title="AyazA , SaeedS , FarooqMU , AhmadF , BahooLA , AmadI . Pre‐labor rupture of membranes at term in patients with an unfavorable cervix: active versus conservative management. Taiwanese Journal of Obstetrics and Gynecology2008;47(2):192‐6. ">Ayaz 2008</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0008" title="JavaidM , TahiraT , HassanS . Management prelabour rupture of the membranes at term; induction of labour compared with expectant. Professional Medical Journal2008;15(2):216‐9. ">Javaid 2008</a>; <a href="./references#CD005302-bbs2-0012" title="MaqboolS , UsmaniAS , BanoB . Comparison of induction and expectant management of prelabour rupture of membranes at term for maternal outcome. Pakistan Journal of Medical and Health Sciences2014; Vol. 8, issue 3:648‐51. ">Maqbool 2014</a>; <a href="./references#CD005302-bbs2-0022" title="TasnimN . Spontaneous pre‐labour rupture of membranes (PROM) at term. Pakistan Journal of Medical Research2000;39(2):66‐9. ">Tasnim 2000</a>), Serbia (<a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>), Sweden (<a href="./references#CD005302-bbs2-0021" title="TamsenL , LyrenasS , CnattingiusS . Premature rupture of the membranes ‐ intervention or not. Gynecologic and Obstetric Investigation1990;29:128‐31. ">Tamsen 1990</a>), the Netherlands (<a href="./references#CD005302-bbs2-0016" title="OttervangerHP , HolmJP , KeirseMJNC . A randomized trial of expectant vs active management for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1992;20(1):223. OttervangerHP , HolmJP , KeirseMJNC . Premature rupture of the membranes at term: induction of labour or expectant care?. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 September; Singapore Vol. 1991:432. OttervangerHP , KeirseMJNC , SmitW , HolmJ . Controlled comparison of induction versus expectant care for prelabour rupture of the membranes at term. Journal of Perinatal Medicine1996;24:237‐42. ">Ottervanger 1996</a>), Turkey (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>), USA (<a href="./references#CD005302-bbs2-0023" title="WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . A comparison of early and delayed induction of labour with spontaneous rupture of membranes at term. Obstetrics &amp; Gynecology1989;74(1):93‐7. WagnerMV , ChinVP , PetersCJ , DrexlerB , NewmanLA . Management of spontaneous rupture of membranes at term. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2‐5; Boston, Massachusetts, USA. 1988:16. ">Wagner 1989</a>), Zimbabwe (<a href="./references#CD005302-bbs2-0013" title="McQueenD . A randomized controlled trial comparing expectant management with active management in early rupture of the membranes. Personal communication1992. ">McQueen 1992</a>), and multiple countries (Canada, the UK, Australia, Israel, Sweden and Denmark) (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>). The results of the review may therefore be applicable to a variety of settings or countries across the world. </p> </section> <section id="CD005302-sec-0146"> <h3 class="title" id="CD005302-sec-0146">Quality of the evidence</h3> <p>The methodological quality of the 23 trials included in this review was low to moderate; overall, most of the trials were judged to be at unclear risk of bias. We were only able to include three 'high‐quality' trials in our sensitivity analyses (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>). Only four of the 23 trials were judged to be at low risk of selection bias (with adequate methods used to generate the random sequence and conceal allocation) (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>). The potential for performance bias was common across the included trials, due to the nature of the intervention. All trials were judged to be at high risk of performance bias, with the exception of three, which used a placebo (<a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>). Eight of the trials were judged to be low risk of detection bias, with blinding of outcome assessment (<a href="./references#CD005302-bbs2-0001" title="AkyolD , MunganT , UnsalA , YukselK . Prelabour rupture of the membranes at term: no advantage of delaying induction for 24 hours. Australian and New Zealand Journal of Obstetrics and Gynaecology1999;39(3):291‐5. ">Akyol 1999</a>; <a href="./references#CD005302-bbs2-0003" title="BeerAM , HeiligerF . Randomized, double‐blind trial of caulophyllum D4 for induction of labour after premature rupture of the membranes at term [Caulophyllum D4 zur geburtsinduktion bei vorzeitigem blasensprung: eine doppelblindstudie]. Geburtshilfe und Frauenheilkunde1999;59:431‐5. ">Beer 1999</a>; <a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0005" title="ChungT , RogersMS , GordonH , ChangA . Prelabour rupture of the membranes at term and unfavourable cervix: a randomized placebo‐controlled trial on early intervention with intravaginal prostaglandin E2 gel. Australian and New Zealand Journal of Obstetrics and Gynaecology1992;32(1):25‐7. ">Chung 1992</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0015" title="NataleR , MilneJK , CampbellMK , PottsPGG , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;171(4):936‐9. NataleR , MilneK , CampbellK , WebsterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. Proceedings of 49th Annual Clinical Meeting of the Society of Obstetricians and Gynaecologists of Canada; 1993 June 22‐26; Ottawa, Ontario, Canada. 1993:15. NataleR , MilneK , CampbellK , WesterK , HalindaE . Management of premature rupture of membranes at term: randomized trial. American Journal of Obstetrics and Gynecology1994;170(1 Pt 2):285. ">Natale 1994</a>; <a href="./references#CD005302-bbs2-0020" title="SperlingLS , SchantzAL , WahlinA , DuunS , JaszczakP , ScherlingB , et al. Management of prelabor rupture of membranes at term. Acta Obstetricia et Gynecologica Scandinavica1993;72:627‐32. ">Sperling 1993</a>). Very few trials reported clearly on losses to follow‐up or missing data (with only eight judged to be low risk of attrition bias (<a href="./references#CD005302-bbs2-0004" title="CheungPC , YeoEL , WongKS , TangLC . Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstetricia et Gynecologica Scandinavica2006;85(9):1128‐33. ">Cheung 2006</a>; <a href="./references#CD005302-bbs2-0006" title="FatimaS , RizviS , SaeedG , JafriA , EusaphA , HaiderR . Expectant vs active management of prelabour rupture of membranes at term. Pakistan Journal of Medical and Health Sciences2015;9(4):1353‐7. ">Fatima 2015</a>; <a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0014" title="MilasinovicL , RadekaG , PetrovicD , OreljM , SavinA . Premature rupture of the membranes: early induction of labor versus expectant management [Rano prsnuce plodovih ovojaka: activni ili ekspektativni pristup resanvanju opstetrickog problema]. Medicinski Pregled1998;51(7‐8):346‐9. ">Milasinovic 1998</a>; <a href="./references#CD005302-bbs2-0017" title="Selmer‐OlsenT , LydersenS , MorkvedS . Does acupuncture used in nulliparous women reduce time from prelabour rupture of membranes at term to active phase of labour? A randomised controlled trial. Acta Obstetricia et Gynecologica Scandinavica2007;86(12):1447‐52. ">Selmer‐Olsen 2007</a>; <a href="./references#CD005302-bbs2-0018" title="ShahK , DoshiH . Premature rupture of membrane at term: Early induction versus expectant management. Journal of Obstetrics and Gynecology of India2012;62(2):172‐5. ">Shah 2012</a>)), and only fives trials were considered to be at low risk of reporting bias (<a href="./references#CD005302-bbs2-0007" title="DiCeccoR , HannahM , HodnettE , FosterG , FarineD , HelewaM . Prelabor rupture of the membranes (PROM) at term: expectant management at home vs. in hospital. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S30. GafniA , GoereeR , MyhrTL , HannahME , BlackhouseG , WillanA , et al. Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. Canadian Medical Association Journal1997;157(11):1519‐25. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. International termPROM trial: a RCT of induction of labour for prelabour rupture of membranes at term. In: Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996; Adelaide, Australia. 1996:A79. HannahM , OhlssonA , FarineD , HewsonS , HodnettE , MyhrT , et al. Vaginal prostaglandin E2 gel vs. intravenous oxytocin vs. expectant management for prelabour rupture of membranes at term: a randomised clinical trial. Proceedings of the 15th Conference of Priorities in Perinatal Care; 1996; South Africa. 1996:14. HannahM , OhlssonA , WangE , MyhrT , FarineD , HewsonS , et al. Inducing labor with iv oxytocin may reduce the risk of neonatal infection in GBS positive women with PROM at term. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S32. HannahM , TermPROM Trial Group. The term prelabour rupture of the membranes (PROM) study. International Journal of Gynecology &amp; Obstetrics1994;46:16. HannahME , OhlssonA , FarineD , HewsonSA , HodnettE , MyhrT , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. HannahME , OhlssonA , WangEE , MatlowA , FosterGA , WillanAR , et al. Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology1997;177(4):780‐5. HodnettED , HannahME , WestonJA , OhlssonA , MyhrTL , WangEE , et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. Birth1997;24(4):214‐20. SeawardG , HannahM , MyhrT , OhlssonA , FarineD , WangE , et al. PROM at term: maternal risk factors for clinical chorioamnionitis. American Journal of Obstetrics and Gynecology1997;176(1 Pt 2):S116. SeawardPG , HannahME , MyhrTL , FarineD , OhlssonA , WangEE , et al. International multicenter term prom study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. American Journal of Obstetrics and Gynecology1998;179(3 Pt 1):635‐9. WestonJ , HannahM , OhlssonA . Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial. Controlled Clinical Trials1993;14:401. ">Hannah 1996</a>; <a href="./references#CD005302-bbs2-0009" title="KrupaFG , CecattiJG , SuritaGC , MilanezHMBP , ParpinelliMA . Misoprostol versus expectant management in premature rupture of membranes at term. BJOG: an international journal of obstetrics and gynaecology2005;112:1284‐90. ">Krupa 2005</a>; <a href="./references#CD005302-bbs2-0010" title="MahmoodTA , DickMJ , SmithNC , TempletonAA . Role of prostaglandin in the management of prelabour rupture of the membranes at term. British Journal of Obstetrics and Gynaecology1992;99:112‐7. MahmoodTA , DickMJW , SmithNC , TempletonA . Management of spontaneous rupture of membranes at term without uterine activity in healthy primigravidae: a prospective study (PGE2 gel versus conservative treatment). The 2nd European Congress of Prostaglandins in Reproduction; 1991 April 30‐May 3; The Hague, Netherlands. 1991:95. ">Mahmood 1992</a>; <a href="./references#CD005302-bbs2-0011" title="MahmoodTA , DickMJW . A randomized trial of management of pre‐labor rupture of membranes at term in multiparous women using vaginal prostaglandin gel. Obstetrics &amp; Gynecology1995;85(1):71‐4. ">Mahmood 1995</a>; <a href="./references#CD005302-bbs2-0019" title="ShalevE , PelegD , EliyahuS , NahumZ . Comparison of 12‐ and 72‐hour expectant management of premature rupture of membranes in term pregnancies. Obstetrics &amp; Gynecology1995;85:766‐8. ">Shalev 1995</a>). In many cases, poor reporting (and limited methodological detail provided) in the included trials led to 'unclear' judgements across one or more of the seven pre‐specified domains for assessing risk of bias. </p> <p>GRADE profiler was used to assess the quality of the evidence for our primary outcomes. The evidence was of <i>moderate quality</i> for perinatal mortality, <i>low quality</i> for maternal infectious morbidity, caesarean section and definite or probable early‐onset neonatal sepsis; and of <i>very low quality</i> for definite early‐onset neonatal sepsis and serious maternal morbidity or mortality. Evidence was mainly downgraded due to the majority of studies contributing data having some serious or very serious design limitations, and for most outcomes estimates were imprecise (<i>see</i><a href="./full#CD005302-tbl-0001">summary of findings Table for the main comparison</a> for a full explanation of reasons for downgrading for each outcome). </p> </section> <section id="CD005302-sec-0147"> <h3 class="title" id="CD005302-sec-0147">Potential biases in the review process</h3> <p>We were aware of the possibility of introducing bias through the review process, and thus tried to minimise bias in a number of ways. Two review authors independently assessed eligibility for inclusion, carried out data extraction and assessed risk of bias. As we included only those trials with reported data for women at 37 weeks' gestation or later at PROM, the evidence we have presented may not represent the total available evidence (given that some trials have been excluded based on also including women at earlier gestations at PROM). However, we developed and applied a priori criteria to enable us to select trials for inclusion in a consistent manner, and all trial selection and assessment steps were performed by two review authors to maximise consistency of judgement. </p> <p>To reduce the potential for publication bias, we conducted a detailed, systematic search process without language or publication status restrictions. It is possible that additional trials comparing planned early birth versus expectant management for PROM at term have been published but not identified. It is also possible that there are other studies that have been conducted but are not yet published. Should any such studies be identified, we will include them in future updates of this review. </p> <p>We explored the potential for publication bias using funnel plots for the review's primary outcomes maternal infectious morbidity, caesarean section and definite or probable early‐onset neonatal sepsis, and secondary outcomes, chorioamnionitis and/or pyrexia, caesarean section for fetal distress, induction of labour, operative vaginal birth, time from ROM to birth, neonatal antibiotic usage and Apgar score less than seven at five minutes. While there was no clear indication of publication bias, there was some asymmetry, possibly associated with small‐study effects (i.e. with small studies of low methodological quality producing exaggerated intervention effect estimates) for three outcomes (maternal infectious morbidity, chorioamnionitis, and neonatal antibiotic usage). </p> </section> <section id="CD005302-sec-0148"> <h3 class="title" id="CD005302-sec-0148">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD005302-bbs2-0083" title="MozurkewichE , ChilimigrasJ , KoepkeE , KeetonK , KingV . Indications for induction of labour: a best‐evidence review. BJOG: an international journal of obstetrics and gynaecology2009;116:626‐36. ">Mozurkewich 2009</a>, has assessed the evidence supporting different indications for induction, including for PROM at term, and identified three systematic reviews (including the previous version of this review, <a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>; <a href="./references#CD005302-bbs2-0078" title="LinMG , NuthalapatyFS , CarverAR , CaseAS , RamseyPS . Misoprostol for labour induction in women with term premature rupture of membranes: a meta‐analysis. Obstetrics and Gynecology2005;106:593‐601. ">Lin 2005</a> and <a href="./references#CD005302-bbs2-0082" title="MozurkewichE , WolfF . Premature rupture of membranes at term: a meta‐analysis of three management systems. Obstetrics and Gynecology1997;89:1035‐43. ">Mozurkewich 1997</a>). Two reviews compared early birth (such as with oxytocin, prostaglandin E2 or <i>Caulophyllum</i>) with conservative management (<a href="./references#CD005302-bbs2-0082" title="MozurkewichE , WolfF . Premature rupture of membranes at term: a meta‐analysis of three management systems. Obstetrics and Gynecology1997;89:1035‐43. ">Mozurkewich 1997</a>: 23 trials, 7493 women; <a href="./references#CD005302-bbs2-0091" title="DareMR , MiddletonP , CrowtherCA , FlenadyV , VaratharajuB . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005302.pub2] ">Dare 2006</a>: 12 trials, 6814 women), and the third assessed misoprostol for induction following PROM at term (<a href="./references#CD005302-bbs2-0078" title="LinMG , NuthalapatyFS , CarverAR , CaseAS , RamseyPS . Misoprostol for labour induction in women with term premature rupture of membranes: a meta‐analysis. Obstetrics and Gynecology2005;106:593‐601. ">Lin 2005</a>: six trials, 452 women). <a href="./references#CD005302-bbs2-0083" title="MozurkewichE , ChilimigrasJ , KoepkeE , KeetonK , KingV . Indications for induction of labour: a best‐evidence review. BJOG: an international journal of obstetrics and gynaecology2009;116:626‐36. ">Mozurkewich 2009</a> concluded, based on these three reviews, that <i>"Expedited induction of labour after PROM reduces chorioamnionitis, endometritis, and admissions to a neonatal intensive care unit. Quality of evidence: high, grade of recommendation for induction of labour: strong".</i> While the general findings of the <a href="./references#CD005302-bbs2-0083" title="MozurkewichE , ChilimigrasJ , KoepkeE , KeetonK , KingV . Indications for induction of labour: a best‐evidence review. BJOG: an international journal of obstetrics and gynaecology2009;116:626‐36. ">Mozurkewich 2009</a> 'best evidence' review are similar to those of our review, the assessments of the quality of the evidence vary. In <a href="./references#CD005302-bbs2-0083" title="MozurkewichE , ChilimigrasJ , KoepkeE , KeetonK , KingV . Indications for induction of labour: a best‐evidence review. BJOG: an international journal of obstetrics and gynaecology2009;116:626‐36. ">Mozurkewich 2009</a>, while the GRADE system was also used, it appears that it was applied differently (i.e. across all outcomes in the three reviews) "<i>In evaluating the strength of the evidence for each indication for induction, we adhered to the GRADE system that classifies the overall quality of evidence as high, moderate, low, and very low"</i>; <a href="./references#CD005302-bbs2-0083" title="MozurkewichE , ChilimigrasJ , KoepkeE , KeetonK , KingV . Indications for induction of labour: a best‐evidence review. BJOG: an international journal of obstetrics and gynaecology2009;116:626‐36. ">Mozurkewich 2009</a> then assigned one of four categories to the evidence: 'net benefits', 'trade‐offs', 'uncertain trade‐offs' or 'net harm'; and subsequently classified a recommendation as 'strong' where the quality of the evidence was considered high, and there was a 'net benefit' for induction of labour. </p> <p><a href="./references#CD005302-bbs2-0080" title="MishaninaE , RogozinskaE , ThatthiT , Uddin‐KhanR , KhanKS , MeadsC . Use of labour induction and risk of cesarean delivery: a systematic review and meta‐analysis. Canadian Medical Association Journal2014;186(9):665‐73. ">Mishanina 2014</a> conducted a broader review of whether the number of caesarean births were higher with induction of labour compared with expectant management and found that overall the number of caesarean births at term were lower when labour was induced (this included women with and without PROM). </p> <p>A number of other current Cochrane reviews are of relevance to our review.</p> <p> <ul id="CD005302-list-0031"> <li> <p><a href="./references#CD005302-bbs2-0062" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735] ">Buchanan 2010</a> assessed planned early birth compared with expectant management for women with preterm PROM. While this review showed no clear differences between groups for neonatal sepsis and perinatal mortality, increases in endometritis and caesarean birth with planned early birth were observed (<a href="./references#CD005302-bbs2-0062" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735] ">Buchanan 2010</a>). The review, however, included only seven trials (690 women), all with methodological weaknesses, and concluded that there is insufficient evidence to guide clinical practice on the benefits and harms of planned early birth compared with expectant management for women with preterm PROM (<a href="./references#CD005302-bbs2-0062" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735] ">Buchanan 2010</a>). The next update of this review will consider the large PPROMT trial of 1839 women (<a href="./references#CD005302-bbs2-0081" title="MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCA , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387:444‐52. ">Morris 2016</a>), which has recently shown expectant management to be a more optimal strategy than immediate birth in women with ruptured membranes close to term. </p> </li> <li> <p><a href="./references#CD005302-bbs2-0071" title="GülmezogluAM , CrowtherCA , MiddletonP , HeatleyE . Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD004945.pub3] ">Gülmezoglu 2012</a> assessed induction of labour compared with expectant management for women at or beyond term. This review, including 22 trials (9383 women) showed reductions in perinatal mortality and caesarean section birth with induction of labour (<a href="./references#CD005302-bbs2-0071" title="GülmezogluAM , CrowtherCA , MiddletonP , HeatleyE . Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD004945.pub3] ">Gülmezoglu 2012</a>). These benefits were however predominately associated with post‐term induction (41 weeks' gestation or later), and the review concluded that as the absolute risk of perinatal mortality is small, women should be appropriately counselled in order to make an informed choice between being scheduled for induction post‐term or monitored without induction (<a href="./references#CD005302-bbs2-0071" title="GülmezogluAM , CrowtherCA , MiddletonP , HeatleyE . Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database of Systematic Reviews2012, Issue 6. [DOI: 10.1002/14651858.CD004945.pub3] ">Gülmezoglu 2012</a>). </p> </li> <li> <p><a href="./references#CD005302-bbs2-0087" title="WojcieszekAM , StockOM , FlenadyV . Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD001807.pub2] ">Wojcieszek 2014</a> assessed the routine use of antibiotics for PROM at or near term. This review, including four trials (2639 women), similarly identified no differences in neonatal sepsis and perinatal mortality. In contrast to our review, <a href="./references#CD005302-bbs2-0087" title="WojcieszekAM , StockOM , FlenadyV . Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD001807.pub2] ">Wojcieszek 2014</a> did not show a difference in maternal infectious morbidity, and an increase in caesarean section with the use of antibiotics was observed (which was largely attributed to one study of 1640 women, in which repeat caesarean section, increased baseline hypertension and pre‐eclampsia were more common in the antibiotic group, despite randomisation processes) (<a href="./references#CD005302-bbs2-0087" title="WojcieszekAM , StockOM , FlenadyV . Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD001807.pub2] ">Wojcieszek 2014</a>). The review concluded that there is no convincing evidence of benefit for mothers or neonates from the routine use of antibiotics for PROM at or near term (<a href="./references#CD005302-bbs2-0087" title="WojcieszekAM , StockOM , FlenadyV . Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database of Systematic Reviews2014, Issue 10. [DOI: 10.1002/14651858.CD001807.pub2] ">Wojcieszek 2014</a>). </p> </li> </ul> </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005302-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD005302-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005302-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005302-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.7 Maternal infectious morbidity (chorioamnionitis, endometritis and/or pyrexia)." data-id="CD005302-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.7 Maternal infectious morbidity (chorioamnionitis, endometritis and/or pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.3 Caesarean section." data-id="CD005302-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.6 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.6 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.9 Chorioamnionitis and/or pyrexia (either suspected or proven)." data-id="CD005302-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.9 Chorioamnionitis and/or pyrexia (either suspected or proven). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.14 Caesarean section for fetal distress." data-id="CD005302-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.14 Caesarean section for fetal distress. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.15 Induction of labour." data-id="CD005302-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.15 Induction of labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.16 Operative vaginal birth." data-id="CD005302-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.16 Operative vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.23 Time from rupture of membranes to birth (hours)." data-id="CD005302-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.23 Time from rupture of membranes to birth (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG12.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.31 Antibiotic usage." data-id="CD005302-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.31 Antibiotic usage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-AFig-FIG13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-AFig-FIG13.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.32 Apgar score less than seven at five minutes." data-id="CD005302-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Planned early birth versus expectant management (subgroups: method of induction), outcome: 1.32 Apgar score less than seven at five minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-AFig-FIG13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis)." data-id="CD005302-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 2 Perinatal mortality (stillbirth or neonatal mortality)." data-id="CD005302-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 2 Perinatal mortality (stillbirth or neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 3 Caesarean section." data-id="CD005302-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 3 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 4 Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit)." data-id="CD005302-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 4 Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 5 Definite early‐onset neonatal sepsis." data-id="CD005302-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 5 Definite early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 6 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 6 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-07.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 7 Maternal infectious morbidity (chorioamnionitis, endometritis and/or pyrexia)." data-id="CD005302-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 7 Maternal infectious morbidity (chorioamnionitis, endometritis and/or pyrexia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 8 Chorioamnionitis (either suspected or proven)." data-id="CD005302-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 8 Chorioamnionitis (either suspected or proven). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-09.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 9 Chorioamnionitis and/or pyrexia (either suspected or proven)." data-id="CD005302-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 9 Chorioamnionitis and/or pyrexia (either suspected or proven). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 10 Endometritis." data-id="CD005302-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 10 Endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 11 Postpartum pyrexia." data-id="CD005302-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 11 Postpartum pyrexia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 12 Postpartum septicaemia." data-id="CD005302-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 12 Postpartum septicaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 13 Postpartum antibiotic usage." data-id="CD005302-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 13 Postpartum antibiotic usage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-14.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 14 Caesarean section for fetal distress." data-id="CD005302-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 14 Caesarean section for fetal distress. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-15.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 15 Induction of labour." data-id="CD005302-fig-0028" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 15 Induction of labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-16.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 16 Operative vaginal birth." data-id="CD005302-fig-0029" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 16 Operative vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 17 Uterine rupture." data-id="CD005302-fig-0030" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 17 Uterine rupture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 18 Epidural analgesia." data-id="CD005302-fig-0031" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 18 Epidural analgesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 19 Postpartum haemorrhage." data-id="CD005302-fig-0032" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 19 Postpartum haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 20 Views of care (VAS 100)." data-id="CD005302-fig-0033" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 20 Views of care (VAS 100). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 21 Views of care." data-id="CD005302-fig-0034" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 21 Views of care. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 22 Views of care." data-id="CD005302-fig-0035" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 22 Views of care. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-23.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 23 Time from rupture of membranes to birth (hours)." data-id="CD005302-fig-0036" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 23 Time from rupture of membranes to birth (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0037"> <p> <div class="table" id="CD005302-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Planned early birth</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expectant management</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>P value</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akyol 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 1: Median (5th, 95th percentiles): 13.0 hours (4.0, 37.2) (N=52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 2: Median (5th, 95th percentiles): 33.9 hours (25.0, 66.1) (N=25)</p> <p>Group 3: Median (5th, 95th percentiles): 11.0 hours (3.0, 20.8) (N=49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 2 had a significant difference compared with Group 1 and 3 (P &lt; 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ayaz 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 11.6 hours (N=42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 17.0 hours (N=42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P &lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fatima 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≤ 5 hours , N= 97</p> <p>6‐10 hours , N=3</p> <p>11‐15 hours, N= 0</p> <p>&gt; 15 hours. N= 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>≤ 5 hours, N=67</p> <p>6‐10 hours, N=27</p> <p>11‐15 hours, N=3</p> <p>&gt; 15 hours. N=3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>" The induction to labour interval was significantly shorter in the misprostol group with P‐value = 7.81 "</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hannah 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oxytocin: Median: 17.2 hours (5th, 95th percentiles: 7.7, 47.1) (N=1258)</p> <p>Prostaglandin: Median: 23.0 hours (5th, 95th percentiles: 8.6, 54.1) (N=1259)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oxytocin: Median: 33.3 hours (5th, 95th percentiles: 10.3, 94.4) (N=1263)</p> <p>Prostaglandin: Median: 32.6 hours (5th, 95th percentiles: 9.9, 106.5) (N=1261)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P &lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Javaid 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Range: 10 to 16 hours (N=50)</p> <p>'Latency period' reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Range: 20 to 25 hours (N=50)</p> <p>'Latency period' reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>"significantly shorter"</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Selmer‐Olsen 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 31.5 hours (N=48)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 25.3 hours (N=53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shah 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>M ean: 13 hours (N=50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 22 hours (N=50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P &lt; 0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sperling 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primiparae: median: 15.6 hours (range: 7.7 to 35.9) (N=33)</p> <p>Multiparae: median: 11.2 hours (range: 8.9 to 19.0) (N=29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Primiparae: median: 19.6 hours (range: 12.8 to 62.1) (N=32)</p> <p>*Multiparae: median: 23.9 hours (8.3 to 40.2) (N=30)</p> <p>*Unclear if these results were for multiparae women or primiparae women who were induced</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P &lt; 0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsen 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 17 hours (range: 10 to 48 hours) for nulliparous women (N=24)</p> <p>Median: 11 hours (range 6 to 48 hours) for parous women (N=19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 27.5 hours (range: 9 to 117) for nulliparous women (N=26)</p> <p>Median: 18.5 hours (range 10 to 98) for parous women (N=24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tasnim 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 12.8 hours (range: 7 to 22 hours) (N=72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 19.8 hours (range: 5 to 40 hours) (N=80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 24 Time from rupture of membranes to birth (hours). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0037">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005302-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 25 Birthweight (g)." data-id="CD005302-fig-0038" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 25 Birthweight (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0039"> <p> <div class="table" id="CD005302-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Planned early birth</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expectant management</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>P value</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tamsen 1990</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nulliparas, mean: 3340 g (N=24)</p> <p>Paras, mean: 3370 g (N=19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nulliparas, mean: 3430 g (N=26)</p> <p>Paras, mean: 3470 g (N=24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tasnim 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 3200 g (range: 2500 to 2900) (N=72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 3100 g (range: 2500 to 2900) (N=80)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nor reported</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 26 Birthweight (g). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0039">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005302-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 27 Cord prolapse." data-id="CD005302-fig-0040" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 27 Cord prolapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 28 Stillbirth." data-id="CD005302-fig-0041" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 28 Stillbirth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 29 Neonatal mortality." data-id="CD005302-fig-0042" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 29 Neonatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 30 Pneumonia." data-id="CD005302-fig-0043" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 30 Pneumonia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-31.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 31 Antibiotic usage." data-id="CD005302-fig-0044" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 31 Antibiotic usage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-32.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 32 Apgar score less than seven at five minutes." data-id="CD005302-fig-0045" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 32 Apgar score less than seven at five minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 33 Use of mechanical ventilation." data-id="CD005302-fig-0046" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 33 Use of mechanical ventilation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 34 Abnormality on cerebral ultrasound (cystic periventricular leukomalacia; intraventricular haemorrhage);." data-id="CD005302-fig-0047" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 34 Abnormality on cerebral ultrasound (cystic periventricular leukomalacia; intraventricular haemorrhage);. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 35 Duration of maternal antenatal or postnatal stay in hospital (days)." data-id="CD005302-fig-0048" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 35 Duration of maternal antenatal or postnatal stay in hospital (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0049"> <p> <div class="table" id="CD005302-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Planned early birth</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Expectant management</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>P value</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Akyol 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time in hospital before birth</p> <p>Group 1: Median (5th, 95th percentiles): 20.5 hours (3.0, 4.8) (N=52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time in hospital before birth</p> <p>Group 2: Median (5th, 95th percentiles): 22.0 (4.9, 45.8) (N=25)</p> <p>Group 3: Median (5th, 95th percentiles): 6.0 hours (1.3, 19.0) (N=49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group 2 had a significant difference compared with Group 1 and 3 (P&lt;0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hannah 1996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time in hospital before birth</p> <p>Oxytocin: Median (5th, 95th percentiles): 12.0 hours (4.6, 32.1) (N=1258)</p> <p>Prostaglandin: Median (5th, 95th percentiles): 17.0 hours (4.8, 38.9) (N=1259)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Time in hospital before birth</p> <p>Oxytocin: Median (5th, 95th percentiles): 16.5 hours (2.9, 66.8) (N=1263)</p> <p>Prostaglandin: Median (5th, 95th percentiles): 16.9 hours (2.0, 69.7) (N=1261)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P&lt;0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Krupa 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Woman stay &gt; 3 days"</p> <p>23/75 (30.7%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Woman stay &gt; 3 days"</p> <p>37/75 (49.3%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P=0.03</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McQueen 1992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maternal hospitalisation</p> <p>Mean (range): 1.65 days (1‐7) (N=20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maternal hospitalisation</p> <p>Mean (range): 2.9 days (1‐6) (N=20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shah 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital stay</p> <p>Mean: 3 days (N=50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital stay</p> <p>Mean: 5 days (N=50)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 36 Duration of maternal antenatal or postnatal stay in hospital (days). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0049">Navigate to figure in review</a></div> </div> <div class="figure" id="CD005302-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 37 Admission to neonatal special or intensive care unit." data-id="CD005302-fig-0050" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 37 Admission to neonatal special or intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 38 Duration of neonatal stay in hospital (hours)." data-id="CD005302-fig-0051" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 38 Duration of neonatal stay in hospital (hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 39 Neonatal stay in special or intensive care unit." data-id="CD005302-fig-0052" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Planned early birth versus expectant management (subgroups: method of induction), Outcome 39 Neonatal stay in special or intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis)." data-id="CD005302-fig-0053" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 2 Caesarean section." data-id="CD005302-fig-0054" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 3 Definite early‐onset neonatal sepsis." data-id="CD005302-fig-0055" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 3 Definite early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 4 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0056" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 4 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality)." data-id="CD005302-fig-0057" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Planned early birth versus expectant management (subgroups: parity), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis)." data-id="CD005302-fig-0058" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 2 Caesarean section." data-id="CD005302-fig-0059" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 3 Definite early‐onset neonatal sepsis." data-id="CD005302-fig-0060" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 3 Definite early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 4 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0061" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 4 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality)." data-id="CD005302-fig-0062" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Planned early birth versus expectant management (subgroups: cervical status), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis)." data-id="CD005302-fig-0063" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 2 Caesarean section." data-id="CD005302-fig-0064" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 3 Definite early‐onset neonatal sepsis." data-id="CD005302-fig-0065" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 3 Definite early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 4 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0066" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 4 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality)." data-id="CD005302-fig-0067" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Planned early birth versus expectant management (subgroups: antibiotic prophylaxis), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis)." data-id="CD005302-fig-0068" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 2 Caesarean section." data-id="CD005302-fig-0069" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 3 Definite early‐onset neonatal sepsis." data-id="CD005302-fig-0070" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 3 Definite early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 4 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0071" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 4 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality)." data-id="CD005302-fig-0072" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Planned early birth versus expectant management (subgroups: digital vaginal examination), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis)." data-id="CD005302-fig-0073" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 1 Maternal infectious morbidity (chorioamnionitis and/or endometritis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 2 Caesarean section." data-id="CD005302-fig-0074" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 3 Definite early‐onset neonatal sepsis." data-id="CD005302-fig-0075" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 3 Definite early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 4 Definite or probable early‐onset neonatal sepsis." data-id="CD005302-fig-0076" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 4 Definite or probable early‐onset neonatal sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005302-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/urn:x-wiley:14651858:media:CD005302:CD005302-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_t/tCD005302-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality)." data-id="CD005302-fig-0077" src="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Planned early birth versus expectant management (sensitivity analysis based on trial quality), Outcome 5 Perinatal mortality (stillbirth or neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/media/CDSR/CD005302/image_n/nCD005302-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005302-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Planned early birth versus expectant management for prelabour rupture of the membranes at term</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Planned early birth versus expectant management for prelabour rupture of the membranes at term </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with prelabour rupture of membranes at term (37 weeks' gestation or later)<br/> <b>Setting:</b> hospital settings<br/> <b>Intervention:</b> planned early birth<br/> <b>Comparison:</b> expectant management </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with expectant management</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with planned early birth</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Maternal infectious morbidity (chorioamnionitis and/or endometritis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>average RR 0.49<br/> (0.33 to 0.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6864<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000<br/> (36 to 79) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>average RR 0.84<br/> (0.69 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>8576<br/> (23 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>126 per 1000<br/> (104 to 156) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>425<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>No events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>no events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>no events</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Definite early‐onset neonatal sepsis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.57<br/> (0.24 to 1.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1303<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000<br/> (5 to 29) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Definite or probable early‐onset neonatal sepsis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/> (0.58 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7314<br/> (16 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/> (24 to 38) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth or neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.47<br/> (0.13 to 1.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6392<br/> (8 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 1000<br/> (0 to 4) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations (‐1): Most of the studies contributing data had design limitations, dominated by a study with low risk of bias </p> <p><sup>2</sup> Inconsistency (‐1): Substantial heterogeneity </p> <p><sup>3</sup> Imprecision (‐1): Wide 95% CI crossing the line of no effect </p> <p><sup>4</sup> Imprecision (‐2): No events; three trials with relatively small sample sizes </p> <p><sup>5</sup> Study limitations (‐2): Most of the studies contributing data had serious design limitations (‐2) </p> <p><sup>6</sup> Imprecision (‐2): Low event rate and wide 95% CI crossing the line of no effect </p> <p><sup>7</sup> Indirectness (‐1): Substantial variation in outcome measurement and reporting of neonatal sepsis </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Planned early birth versus expectant management for prelabour rupture of the membranes at term</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/full#CD005302-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005302-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: method of induction)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal infectious morbidity (chorioamnionitis and/or endometritis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.33, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Intravenous oxytocin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.40, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Oral misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Sublingual misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.12, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Vaginal prostaglandin E2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2595</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.39, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Perinatal mortality (stillbirth or neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Intravenous oxytocin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3402</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.10, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Vaginal misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Vaginal prostaglandin E2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.05, 5.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.69, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Acupuncture</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.31 [0.70, 15.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Intravenous oxytocin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.76, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Oral Caulophyllum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.26, 98.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Oral misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>482</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.30, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Sublingual misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.45, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Vaginal misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.37, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7 Vaginal prostaglandin E2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3074</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.75, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Serious maternal morbidity or mortality (e.g. death, cardiac arrest, respiratory arrest, admission to intensive care unit) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Intravenous oxytocin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>275</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Vaginal misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Definite early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Intravenous oxytocin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1024</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.20, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Vaginal prostaglandin E2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Definite or probable early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.58, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Intravenous oxytocin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.43, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Oral misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.18, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Vaginal misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Vaginal prostaglandin E2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3074</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.64, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal infectious morbidity (chorioamnionitis, endometritis and/or pyrexia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7667</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.38, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Intravenous oxytocin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3751</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.43, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Oral misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>382</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.08, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Sublingual misoprostol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.12, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Vaginal prostaglandin E2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2974</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.49, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Chorioamnionitis (either suspected or proven) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.37, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Chorioamnionitis and/or pyrexia (either suspected or proven) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7677</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.42, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.05, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Postpartum pyrexia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.45, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Postpartum septicaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.07, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Postpartum antibiotic usage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>685</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.40, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Caesarean section for fetal distress <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1851</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.60, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Induction of labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6945</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.41 [2.87, 4.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Operative vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6379</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.67, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Uterine rupture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [0.12, 68.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Epidural analgesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>585</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.80, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Postpartum haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>520</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.14, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Views of care (VAS 100) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.80 [4.36, 19.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 ‘How do you experience your plan of treatment after PROM?’</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.80 [4.36, 19.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Views of care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.36, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 Nothing liked about treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.36, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Views of care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [1.10, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 Nothing disliked about treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [1.10, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Time from rupture of membranes to birth (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1484</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.10 [‐12.15, ‐8.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Time from rupture of membranes to birth (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Birthweight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1043</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐79.25 [‐124.96, ‐33.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Birthweight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Cord prolapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5740</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.09, 2.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Stillbirth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Neonatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.04, 9.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Antibiotic usage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6427</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.44, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Apgar score less than seven at five minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.77, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Use of mechanical ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.33, 2.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Abnormality on cerebral ultrasound (cystic periventricular leukomalacia; intraventricular haemorrhage); <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Duration of maternal antenatal or postnatal stay in hospital (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.20, ‐0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Duration of maternal antenatal or postnatal stay in hospital (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Admission to neonatal special or intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.66, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Duration of neonatal stay in hospital (hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.0 [‐21.96, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Neonatal stay in special or intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5691</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.61, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: method of induction)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005302-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: parity)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal infectious morbidity (chorioamnionitis and/or endometritis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.31, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Nulliparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 3.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Nulliparous and multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.32, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.69, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Nulliparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3519</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.76, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.21, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Nulliparous and multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2687</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.67, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Definite early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Nulliparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Nulliparous and multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1083</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.20, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Definite or probable early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.58, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Nulliparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>184</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.05, 1.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Nulliparous and multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6910</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.59, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality (stillbirth or neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Nulliparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Nulliparous and multiparous women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6072</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.66]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: parity)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005302-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: cervical status)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal infectious morbidity (chorioamnionitis and/or endometritis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.31, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.11, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Favourable and unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.51, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Cervical status: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.10, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.67, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>552</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.42, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Favourable and unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.79, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Cervical status: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1780</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.56, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Definite early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.01, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Favourable and unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Cervical status: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.29, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Definite or probable early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.58, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>552</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.19, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Favourable and unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5783</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.60, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Cervical status: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>979</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.50, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality (stillbirth or neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Favourable and unfavourable cervices</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.13, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Cervical status: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>879</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.72]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: cervical status)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005302-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: antibiotic prophylaxis)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal infectious morbidity (chorioamnionitis and/or endometritis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.31, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Routine antibiotic prophylaxis: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>644</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.12, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Routine antibiotic prophylaxis: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.10, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Routine antibiotic prophylaxis: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Routine antibiotic prophylaxis: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6021</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.51, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.67, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Routine antibiotic prophylaxis: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>996</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.40, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Routine antibiotic prophylaxis: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.66, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Routine antibiotic prophylaxis: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.41, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Routine antibiotic prophylaxis: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6800</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.78, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Definite early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Routine antibiotic prophylaxis: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Routine antibiotic prophylaxis: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Routine antibiotic prophylaxis: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.20, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Definite or probable early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.58, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Routine antibiotic prophylaxis: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.54, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Routine antibiotic prophylaxis: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>533</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.23, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Routine antibiotic prophylaxis: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Routine antibiotic prophylaxis: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.56, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality (stillbirth or neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Routine antibiotic prophylaxis: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Routine antibiotic prophylaxis: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>360</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Routine antibiotic prophylaxis: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Routine antibiotic prophylaxis: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5757</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.13, 2.00]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: antibiotic prophylaxis)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005302-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: digital vaginal examination)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal infectious morbidity (chorioamnionitis and/or endometritis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.31, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Digital vaginal examination: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>441</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.37, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Digital vaginal examination: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.29, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Digital vaginal examination: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.05, 3.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Digital vaginal examination: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.12, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.67, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Digital vaginal examination: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.77, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Digital vaginal examination: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.80, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Digital vaginal examination: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>751</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.19, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Digital vaginal examination: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>933</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.48, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Definite early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1303</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Digital vaginal examination: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Digital vaginal examination: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [0.01, 1.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Digital vaginal examination: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.29, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Definite or probable early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7314</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.58, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Digital vaginal examination: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.46, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Digital vaginal examination: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.57, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Digital vaginal examination: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.25, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Digital vaginal examination: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>273</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality (stillbirth or neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Digital vaginal examination: all women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>512</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Digital vaginal examination: some women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.13, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Digital vaginal examination: no women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Digital vaginal examination: not clear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>273</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Planned early birth versus expectant management (subgroups: digital vaginal examination)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005302-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Planned early birth versus expectant management (sensitivity analysis based on trial quality)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal infectious morbidity (chorioamnionitis and/or endometritis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.50, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.81, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Definite early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Definite or probable early‐onset neonatal sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.66, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality (stillbirth or neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5041</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.13, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Planned early birth versus expectant management (sensitivity analysis based on trial quality)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005302.pub3/references#CD005302-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005302.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD005302-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD005302-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005302-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD005302-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ru#CD005302-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005302-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005302\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005302\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005302\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005302\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005302\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005302.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005302.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005302.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005302.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005302.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714055575"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005302.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714055579"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005302.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6556ddd1937d',t:'MTc0MDcxNDA1NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 